Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Acquir Immune Defic Syndr
    October 2017

  1. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery: Erratum.
    J Acquir Immune Defic Syndr. 2017;76:e64.
    >> Share

  2. WILTON J, Mishra S, Tan DHS
    Considerations for Using the HIRI-MSM Screening Tool to Identify MSM Who Would Benefit Most From PrEP.
    J Acquir Immune Defic Syndr. 2017;76:e58-e61.
    >> Share

  3. SANDFORT TGM, Knox JR, Alcala C, El-Bassel N, et al
    Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2017;76:e34-e46.
    >> Share

  4. ONDIEK J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, et al
    Multicountry Validation of SAMBA - A Novel Molecular Point-of-Care Test for HIV-1 Detection in Resource-Limited Setting.
    J Acquir Immune Defic Syndr. 2017;76:e52-e57.
    >> Share

  5. FABBIANI M, Muscatello A, Perseghin P, Bani M, et al
    Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated With the Evolution of Cognitive Performance in HIV-Infected Patients.
    J Acquir Immune Defic Syndr. 2017;76:219-224.
    >> Share

  6. SMOLDERS EJ, Smit C, T M M de Kanter C, Dofferiiof ASM, et al
    Brief Report: High Need to Switch cART or Comedication With the Initiation of DAAs in Elderly HIV/HCV-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2017;76:193-199.
    >> Share

  7. MISRA K, Udeagu CC
    Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
    J Acquir Immune Defic Syndr. 2017;76:132-140.
    >> Share

    September 2017
  8. FERRETTI F, Mora-Peris B, Underwood J, Waldman A, et al
    Cognitive Impairment in a Clinical Setting.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001547.
    >> Share

  9. ECKARD AR, O'Riordan MA, Rosebush JC, Ruff JH, et al
    Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-infected Youth.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001545.
    >> Share

  10. ZHANG HL, Rhea SK, Hurt CB, Mobley VL, et al
    HIV pre-exposure prophylaxis implementation at local health departments: a statewide assessment of activities and barriers.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001546.
    >> Share

  11. STONER MCD, Edwards JK, Miller WC, Aiello AE, et al
    The effect of schooling on age-disparate relationships and number of sexual partners among young women in rural South Africa enrolled in HPTN 068.
    J Acquir Immune Defic Syndr. 2017 Sep 11. doi: 10.1097/QAI.0000000000001544.
    >> Share

  12. LANDOVITZ RJ, Beymer M, Kofron R, Amico KR, et al
    Plasma Tenofovir-levels to Support Adherence to TDF/FTC Pre-exposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001538.
    >> Share

  13. FIRNHABER C, Swarts A, Goeieman B, Rakhombe N, et al
    Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001539.
    >> Share

  14. VALVERDE EE, Oster AM, Xu S, Wertheim JO, et al
    HIV Transmission Dynamics among Foreign-born Persons in the United States.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001541.
    >> Share

  15. PLOTZKER R, Seekaew P, Jantarapakde J, Pengnonyang S, et al
    The Importance of Risk Perception: Predictors of PrEP Acceptance Among Thai MSM and TG Women at a Community-Based Health Service.
    J Acquir Immune Defic Syndr. 2017 Sep 7. doi: 10.1097/QAI.0000000000001536.
    >> Share

  16. TRAM KH, Mwangwa F, Atukunda M, Owaraganise A, et al
    Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001540.
    >> Share

  17. RICE WS, Burnham K, Mugavero MJ, Raper JL, et al
    Association between Internalized HIV-related Stigma and HIV Care Visit Adherence.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001543.
    >> Share

  18. MOORE DM, Cui Z, Lachowsky NJ, Rich AJ, et al
    Increasing HIV treatment optimism but no changes in HIV risk behaviour among men who have sex with men (MSM) in Vancouver, Canada.
    J Acquir Immune Defic Syndr. 2017 Sep 6. doi: 10.1097/QAI.0000000000001542.
    >> Share


  19. Distribution of Behavioral Patterns Before Infection Among San Francisco Men Who Have Sex With Men Newly Infected With HIV in 2014: Erratum.
    J Acquir Immune Defic Syndr. 2017;76:e33.
    >> Share

  20. GONZALEZ-SERNA A, Ajaykumar A, Gadawski I, Munoz-Fernandez MA, et al
    Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion.
    J Acquir Immune Defic Syndr. 2017;76:e29-e32.
    >> Share

  21. DROBENIUC AM, Spaulding A
    Censoring of HIV Viremia Data of Reincarcerated Individuals: A Response to Wohl et al.
    J Acquir Immune Defic Syndr. 2017;76:e22-e23.
    >> Share

  22. CHAU KH, Scherzer R, Grunfeld C, Hsue PY, et al
    CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.
    J Acquir Immune Defic Syndr. 2017;76:90-97.
    >> Share

  23. MONROE AK, Fleishman JA, Voss CC, Keruly JC, et al
    Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical Data.
    J Acquir Immune Defic Syndr. 2017;76:82-89.
    >> Share

  24. LACOURSE SM, Deya RW, Graham SM, Masese LN, et al
    Evaluation of the Isoniazid Preventive Therapy Care Cascade Among HIV-Positive Female Sex Workers in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2017;76:74-81.
    >> Share

  25. YUEN T, Brouillette MJ, Fellows LK, Ellis RJ, et al
    Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection.
    J Acquir Immune Defic Syndr. 2017;76:48-54.
    >> Share

  26. NGANDU NK, Carlson JM, Chopera DR, Ndabambi N, et al
    Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.
    J Acquir Immune Defic Syndr. 2017;76:43-47.
    >> Share

  27. JACOBSON DL, Stephensen CB, Miller TL, Patel K, et al
    Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children.
    J Acquir Immune Defic Syndr. 2017;76:33-42.
    >> Share

  28. DOMBROWSKI JC, Dorabjee J, Strathdee SA
    Editorial: Atrocity in the Philippines: How Rodrigo Duterte's War on Drug Users May Exacerbate the Burgeoning HIV Epidemic.
    J Acquir Immune Defic Syndr. 2017;76:23-25.
    >> Share

  29. RANSOME Y, Dean LT, Crawford ND, Metzger DS, et al
    How Do Social Capital and HIV/AIDS Outcomes Geographically Cluster and Which Sociocontextual Mechanisms Predict Differences Across Clusters?
    J Acquir Immune Defic Syndr. 2017;76:13-22.
    >> Share

    August 2017
  30. MARKOWITZ M, Grossman H, Anderson PL, Grant R, et al
    Newly Acquired Infection with Multi-Drug Resistant HIV-1 in a Patient Adherent to Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001534.
    >> Share

  31. GOLDSTONE RN, Hasan SR, Goldstone SE
    Radiofrequency ablation therapy for anal intraepithelial neoplasia: results from a single-center prospective pilot study in HIV+ participants.
    J Acquir Immune Defic Syndr. 2017 Aug 26. doi: 10.1097/QAI.0000000000001535.
    >> Share

  32. HOFFMAN S, Tymejczyk O, Kulkarni S, Lahuerta M, et al
    Stigma And HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART.
    J Acquir Immune Defic Syndr. 2017 Aug 22. doi: 10.1097/QAI.0000000000001530.
    >> Share

  33. SMITH DK, Van Handel M, Huggins R
    Estimated coverage to address financial barriers to HIV preexposure prophylaxis among persons with indications for its use, United States, 2015.
    J Acquir Immune Defic Syndr. 2017 Aug 22. doi: 10.1097/QAI.0000000000001532.
    >> Share

  34. PINTYE J, Bacchetti P, Teeraananchai S, Kerr S, et al
    Brief Report: Lopinavir Hair Concentrations are the Strongest Predictor of Viremia in HIV-infected Asian Children and Adolescents on Second-line Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001527.
    >> Share

  35. NORWOOD J, Koethe JR, Turner M, Bofill C, et al
    Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001525.
    >> Share

  36. DILLON SM, Castleman MJ, Frank DN, Austin GL, et al
    Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001523.
    >> Share

  37. VOJNOV L, Markby J, Boeke C, Penazzato M, et al
    Impact of SMS/GPRS printers in reducing time to early infant diagnosis compared to routine result reporting: a systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2017 Aug 18. doi: 10.1097/QAI.0000000000001526.
    >> Share

  38. MANNE-GOEHLER J, Montana L, Gomez-Olive FX, Rohr J, et al
    The ART Advantage: Health Care Utilization for Diabetes and Hypertension in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;75:561-567.
    >> Share

  39. MAYER KH, Jones D, Oldenburg C, Jain S, et al
    Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens.
    J Acquir Immune Defic Syndr. 2017;75:535-539.
    >> Share

  40. TAYLOR BS, So-Armah K, Tate JP, Marconi VC, et al
    HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
    J Acquir Immune Defic Syndr. 2017;75:500-508.
    >> Share

  41. HENRIQUEZ JE, Rizzo MD, Schulz MA, Crawford RB, et al
    Delta9-Tetrahydrocannabinol Suppresses Secretion of IFNalpha by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals.
    J Acquir Immune Defic Syndr. 2017;75:588-596.
    >> Share

  42. YEN YF, Jen IA, Chen M, Lan YC, et al
    HIV Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-Based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2017;75:493-499.
    >> Share

  43. GIANOTTI N, Marchetti G, Antinori A, Saracino A, et al
    Drop in CD4+ counts below 200 cells/microL after reaching (or starting from) values higher than 350 cells/microL in HIV-infected patients with virological suppression.
    J Acquir Immune Defic Syndr. 2017 Aug 12. doi: 10.1097/QAI.0000000000001522.
    >> Share

  44. MOMPLAISIR F, Hussein M, Tobin-Fiore D, Smith L, et al
    Racial Inequities in HIV Prevalence and Composition of Risk Networks among People Who Inject Drugs in HPTN 037.
    J Acquir Immune Defic Syndr. 2017 Aug 12. doi: 10.1097/QAI.0000000000001521.
    >> Share

  45. STRAIN JF, Burdo TH, Song SK, Sun P, et al
    Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients.
    J Acquir Immune Defic Syndr. 2017 Aug 5. doi: 10.1097/QAI.0000000000001513.
    >> Share

  46. PACHANKIS JE, Hatzenbuehler ML, Berg RC, Fernandez-Davila P, et al
    Anti-LGBT and Anti-Immigrant Structural Stigma: An Intersectional Analysis of Sexual Minority Men's HIV Risk When Migrating to or Within Europe.
    J Acquir Immune Defic Syndr. 2017 Aug 4. doi: 10.1097/QAI.0000000000001519.
    >> Share

  47. SUGAR NR, Schilling KA, Kim S, Ahmed A, et al
    Integrating Household Water Treatment, Hand Washing, and Insecticide-Treated Bed Nets into Pediatric HIV Care in Mombasa, Kenya: Impact on Diarrhea and Malaria Risk.
    J Acquir Immune Defic Syndr. 2017 Aug 4. doi: 10.1097/QAI.0000000000001520.
    >> Share

  48. DE WEERDT J, Beegle K, Dercon S
    Orphanhood and Self-esteem: an 18-year longitudinal study from an HIV affected area in Tanzania.
    J Acquir Immune Defic Syndr. 2017 Aug 2. doi: 10.1097/QAI.0000000000001504.
    >> Share

  49. DE LUCA A, Lorenzini P, Castagna A, Puoti M, et al
    Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75:465-471.
    >> Share

  50. FLANDRE P, Marcelin AG, Calvez V
    Addition of Etravirine Does Not Enhance the Initial Decline of HIV-1 RNA in Treatment-Experienced Patients Receiving Raltegravir.
    J Acquir Immune Defic Syndr. 2017;75:448-454.
    >> Share

  51. SMITH LR, Yore J, Triplett DP, Urada L, et al
    Impact of Sexual Violence Across the Lifespan on HIV Risk Behaviors Among Transgender Women and Cisgender People Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75:408-416.
    >> Share

  52. MCLEAN E, Price A, Chihana M, Kayuni N, et al
    Changes in Fertility at the Population Level in the Era of ART in Rural Malawi.
    J Acquir Immune Defic Syndr. 2017;75:391-398.
    >> Share

  53. SINGH D, Ghate M, Godbole S, Kulkarni S, et al
    CD1d-Restricted Natural Killer T Cells Are Preserved in Indian Long-Term Nonprogressors.
    J Acquir Immune Defic Syndr. 2017;75:e104-e112.
    >> Share

  54. LAHUERTA M, Zerbe A, Baggaley R, Falcao J, et al
    Feasibility, Acceptability And Adherence With Short Term Hiv Pre-Exposure Prophylaxis In Female Sexual Partners Of Migrant Miners In Mozambique.
    J Acquir Immune Defic Syndr. 2017 Aug 1. doi: 10.1097/QAI.0000000000001518.
    >> Share

    July 2017
  55. PINTYE J, Beima-Sofie KM, Kimemia G, Ngure K, et al
    "I did not want to give birth to a child who has HIV": Experiences using PrEP during pregnancy among HIV-uninfected Kenyan women in HIV-serodiscordant couples.
    J Acquir Immune Defic Syndr. 2017 Jul 31. doi: 10.1097/QAI.0000000000001516.
    >> Share

  56. PFEIFFER JT, Napua M, Wagenaar BH, Chale F, et al
    A stepped wedge cluster randomized controlled trial to promote Option B+ retention in central Mozambique.
    J Acquir Immune Defic Syndr. 2017 Jul 31. doi: 10.1097/QAI.0000000000001515.
    >> Share

  57. RAIFMAN JR, Gebo KA, Mathews WC, Korthuis PT, et al
    Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004-2014.
    J Acquir Immune Defic Syndr. 2017 Jul 31. doi: 10.1097/QAI.0000000000001514.
    >> Share

  58. BENGTSON AM, Pence BW, Mollan KR, Edwards JK, et al
    The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001510.
    >> Share

  59. GREER AE, Ou SS, Wilson E, Piwowar-Manning E, et al
    A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001511.
    >> Share

  60. BRAUNSTEIN SL, Robbins RS, Daskalakis DC
    Missed Opportunities: Adapting the HIV Care Continuum to Reduce HIV-related Deaths.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001509.
    >> Share

  61. PITTALIS S, Orchi N, Carli G, Navarra A, et al
    HIV self-testing in Italy.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001507.
    >> Share

  62. KUNZWEILER CP, Bailey RC, Okall DO, Graham SM, et al
    Factors associated with prevalent HIV infection among Kenyan MSM: The Anza Mapema Study.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001512.
    >> Share

  63. SCHAFFER EM, Agot K, Thirumurthy H
    The Association between Intimate Partner Violence and Women's Distribution and Use of HIV Self-Tests with Male Partners: Evidence from a Cohort Study in Kenya.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001502.
    >> Share

  64. HUSNIK MJ, Brown ER, Marzinke M, Livant E, et al
    Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001503.
    >> Share

  65. LODI S, Costagliola D, Sabin C, Amo JD, et al
    Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.
    J Acquir Immune Defic Syndr. 2017 Jul 21. doi: 10.1097/QAI.0000000000001498.
    >> Share

  66. JOHNSON AS, Song R, Hall HI
    Estimated HIV incidence, prevalence, and undiagnosed infections in US states and Washington, DC, 2010-2014.
    J Acquir Immune Defic Syndr. 2017 Jul 10. doi: 10.1097/QAI.0000000000001495.
    >> Share

  67. CHIKWARI CD, Ferrand RA, Simms V
    Association between self-reported adherence and HIV viral load suppression among older children and adolescents.
    J Acquir Immune Defic Syndr. 2017 Jul 8. doi: 10.1097/QAI.0000000000001501.
    >> Share

  68. ROLLE CP, Rosenberg ES, Siegler AJ, Sanchez TH, et al
    Challenges in Translating PrEP Interest into Uptake in an Observational Study of Young Black MSM.
    J Acquir Immune Defic Syndr. 2017 Jul 8. doi: 10.1097/QAI.0000000000001497.
    >> Share

  69. CALCAGNO A, Piconi S, Foca E, Nozza S, et al
    Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-infected Patient.
    J Acquir Immune Defic Syndr. 2017 Jul 8. doi: 10.1097/QAI.0000000000001496.
    >> Share

  70. CHEN M, Dou Z, Wang L, Wu Y, et al
    Gender differences in outcomes of antiretroviral treatment among HIV-infected patients in China: a retrospective cohort study, 2010-2015.
    J Acquir Immune Defic Syndr. 2017 Jul 8. doi: 10.1097/QAI.0000000000001500.
    >> Share

  71. JIAMSAKUL A, Kariminia A, Althoff KN, Cesar C, et al
    HIV viral load suppression in adults and children receiving antiretroviral therapy - results from the IeDEA collaboration.
    J Acquir Immune Defic Syndr. 2017 Jul 8. doi: 10.1097/QAI.0000000000001499.
    >> Share

  72. DAVEY DLJ, M Wall K, Kilembe W, Khu Naw H, et al
    HIV incidence and predictors of HIV acquisition from an outside partner in serodiscordant couples in Lusaka, Zambia, 1995-2012.
    J Acquir Immune Defic Syndr. 2017 Jul 4. doi: 10.1097/QAI.0000000000001494.
    >> Share

  73. BLITZ S, Antoniou T, Burchell A, Walmsley S, et al
    The use of multistate models to examine associations of stress and adherence with transitions among HIV care states observed in a clinical HIV cohort.
    J Acquir Immune Defic Syndr. 2017 Jul 3. doi: 10.1097/QAI.0000000000001493.
    >> Share

  74. COUDERC C, Dembele Keita B, Anoma C, Wade AS, et al
    Is PrEP Needed for MSM in West Africa? HIV Incidence in a Prospective Multicountry Cohort.
    J Acquir Immune Defic Syndr. 2017;75:e80-e82.
    >> Share

  75. MAHESWARAN H, Petrou S, MacPherson P, Kumwenda F, et al
    Economic Costs and Health-Related Quality of Life Outcomes of HIV Treatment After Self- and Facility-Based HIV Testing in a Cluster Randomized Trial.
    J Acquir Immune Defic Syndr. 2017;75:280-289.
    >> Share

  76. PATRICK R, Greenberg A, Magnus M, Opoku J, et al
    Development of an HIV Testing Dashboard to Complement the HIV Care Continuum Among MSM, PWID, and Heterosexuals in Washington, DC, 2007-2015.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S397-S407.
    >> Share

  77. HOOTS BE, Finlayson TJ, Broz D, Paz-Bailey G, et al
    Antiretroviral Therapy Use Among HIV-Infected People Who Inject Drugs-20 Cities, United States, 2009-2015.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S392-S396.
    >> Share

  78. WALTERS SM, Rivera AV, Starbuck L, Reilly KH, et al
    Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S383-S391.
    >> Share

  79. PATRICK R, Forrest D, Cardenas G, Opoku J, et al
    Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S375-S382.
    >> Share

  80. OLIVER SE, Hoots BE, Paz-Bailey G, Markowitz LE, et al
    Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S370-S374.
    >> Share

  81. AN Q, Wejnert C, Bernstein K, Paz-Bailey G, et al
    Syphilis Screening and Diagnosis Among Men Who Have Sex With Men, 2008-2014, 20 U.S. Cities.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S363-S369.
    >> Share

  82. VINCENT W, McFarland W, Raymond HF
    What Factors Are Associated With Receiving a Recommendation to Get Tested for HIV by Health Care Providers Among Men Who Have Sex With Men?
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S357-S362.
    >> Share

  83. ROBINSON WT, Zarwell M, Gruber D
    Preferences for Home-Based HIV Testing Among Heterosexuals at Increased Risk for HIV/AIDS: New Orleans, Louisiana, 2013.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S352-S356.
    >> Share

  84. BURT RD, Tinsley J, Glick SN
    A Decline in HIV Testing Among Persons Who Inject Drugs in the Seattle Area, 2004-2015.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S346-S351.
    >> Share

  85. ROBINSON WT, Kazbour C, Nassau T, Fisher K, et al
    Brief Report: Nonfatal Overdose Events Among Persons Who Inject Drugs: Findings From Seven National HIV Behavioral Surveillance Cities 2009 & 2012.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S341-S345.
    >> Share

  86. NERLANDER LM, Hess KL, Rose CE, Sionean C, et al
    Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S333-S340.
    >> Share

  87. NEAIGUS A, Reilly KH, Jenness SM, Hagan H, et al
    Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S325-S332.
    >> Share

  88. MACKESY-AMITI ME, Boodram B, Spiller MW, Paz-Bailey G, et al
    Injection-Related Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Across 20 US Cities.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S316-S324.
    >> Share

  89. GUIGAYOMA J, Chen YH, Snowden JM, Santos GM, et al
    Self-Perceived Viral Load and Sexual Risk Behavior Among Known HIV-Positive MSM in San Francisco, 2014.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S309-S315.
    >> Share

  90. GERMAN D, Brady K, Kuo I, Opoku J, et al
    Characteristics of Black Men Who Have Sex With Men in Baltimore, Philadelphia, and Washington, D.C.: Geographic Diversity in Socio-Demographics and HIV Transmission Risk.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S296-S308.
    >> Share

  91. PAZ-BAILEY G, Hoots BE, Xia M, Finlayson T, et al
    Trends in Internet Use Among Men Who Have Sex With Men in the United States.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S288-S295.
    >> Share

  92. SHADAKER S, Magee M, Paz-Bailey G, Hoots BE, et al
    Characteristics and Risk Behaviors of Men Who Have Sex With Men and Women Compared With Men Who Have Sex With Men-20 US Cities, 2011 and 2014.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S281-S287.
    >> Share

  93. RAYMOND HF, Al-Tayyib A, Neaigus A, Reilly KH, et al
    HIV Among MSM and Heterosexual Women in the United States: An Ecologic Analysis.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S276-S280.
    >> Share

  94. DENSON DJ, Padgett PM, Pitts N, Paz-Bailey G, et al
    Health Care Use and HIV-Related Behaviors of Black and Latina Transgender Women in 3 US Metropolitan Areas: Results From the Transgender HIV Behavioral Survey.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S268-S275.
    >> Share

  95. WISE A, Finlayson T, Nerlander L, Sionean C, et al
    Incarceration, Sexual Risk-Related Behaviors, and HIV Infection Among Women at Increased Risk of HIV Infection, 20 United States Cities.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S261-S267.
    >> Share

  96. IVY W 3RD, Nwangwu-Ike N, Paz-Bailey G
    Reductions in HIV Diagnoses Among African American Women: A Search for Explanations.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S253-S260.
    >> Share

  97. WEJNERT C, Raymond HF, Robbins T, Prejean J, et al
    Achieving Greater HIV Prevention Impact Through CDC's National HIV Behavioral Surveillance System.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 3:S249-S252.
    >> Share

    June 2017
  98. HAWKINS C, Christian B, Fabian E, Macha I, et al
    HIV/HBV co-infection is a significant risk factor for liver fibrosis in Tanzanian HIV-infected adults.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001491.
    >> Share

  99. CLIFFORD KM, Samboju V, Cobigo Y, Milanini B, et al
    Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Over Age 60.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001489.
    >> Share

  100. SMOLDERS EJ, Smit C, Tmm De Kanter C, Dofferhoff A, et al
    High need to switch cART or co-medication with the initiation of DAAs in elderly HIV/HCV co-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001488.
    >> Share

  101. VERDERY AM, Siripong N, Pence BW
    Social network clustering and the spread of HIV/AIDS among persons who inject drugs in two cities in the Philippines.
    J Acquir Immune Defic Syndr. 2017 Jun 22. doi: 10.1097/QAI.0000000000001485.
    >> Share

  102. LEE GQ, McCluskey S, Boum Y 2nd, Hunt PW, et al
    Should abacavir be a first-line alternative for adults with HIV in sub-Saharan Africa?
    J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001487.
    >> Share

  103. GLIDDEN DV, Mulligan K, McMahan V, Anderson PL, et al
    Recovery of Bone Mineral Density Following Discontinuation of Tenofovir-Based HIV Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001475.
    >> Share

  104. LOPES BLW, Eron J Jr, Mugavero MJ, Miller W, et al
    HIV Care Initiation Delay among Rural Residents in the Southeastern United States, 1996 to 2012.
    J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001483.
    >> Share

  105. FABBIANI M, Muscatello A, Perseghin P, Bani M, et al
    Peripheral monocytes/macrophages phenotypes associated to the evolution of cognitive performance in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001480.
    >> Share

  106. JESSON J, Coulibaly A, Sylla M, N'diaye C, et al
    Evaluation of a nutritional support intervention in malnourished HIV-infected children in Bamako, Mali.
    J Acquir Immune Defic Syndr. 2017 Jun 19. doi: 10.1097/QAI.0000000000001484.
    >> Share

  107. MCCLUSKEY SM, Boum Y 2nd, Musinguzi N, Haberer JE, et al
    Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.
    J Acquir Immune Defic Syndr. 2017 Jun 15. doi: 10.1097/QAI.0000000000001479.
    >> Share

  108. DAVY-MENDEZ T, Eron JJ, Zakharova O, Wohl DA, et al
    Increased Persistence of Initial Treatment for HIV Infection with Modern Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Jun 15. doi: 10.1097/QAI.0000000000001481.
    >> Share

  109. WOHL AR, Benbow N, Tejero J, Johnson C, et al
    Antiretroviral Prescription and Viral Suppression in a Representative Sample of HIV-Infected Persons in Care in Four Large Metropolitan Areas of the United States, Medical Monitoring Project, 2011[FIGURE DASH]2013.
    J Acquir Immune Defic Syndr. 2017 Jun 15. doi: 10.1097/QAI.0000000000001482.
    >> Share

  110. SHAKIRZYANOVA M, Kong XP, Cheng-Mayer C
    Determinants of HIV-1 CD4-independent brain adaptation.
    J Acquir Immune Defic Syndr. 2017 Jun 15. doi: 10.1097/QAI.0000000000001478.
    >> Share

  111. ONDIEK J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, et al
    Multi-country validation of SAMBA - A novel molecular point-of- care test for HIV-1 detection in resource-limited setting.
    J Acquir Immune Defic Syndr. 2017 Jun 9. doi: 10.1097/QAI.0000000000001476.
    >> Share

  112. TJIAM MC, Morshidi MA, Sariputra L, Martin JN, et al
    The association of HIV-1 Gag-specific IgG antibodies with natural control of HIV-1 infection in individuals not carrying HLA-B*57: 01 is only observed in viremic controllers.
    J Acquir Immune Defic Syndr. 2017 Jun 9. doi: 10.1097/QAI.0000000000001477.
    >> Share

  113. REBEIRO PF, Bakoyannis G, Musick BS, Braithwaite RS, et al
    An Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the Better.
    J Acquir Immune Defic Syndr. 2017 Jun 9. doi: 10.1097/QAI.0000000000001474.
    >> Share

  114. LAVERICK R, Haddow L, Daskalopoulou M, Lampe F, et al
    Self-reported difficulties with everyday function, cognitive symptoms and cognitive function in people with HIV.
    J Acquir Immune Defic Syndr. 2017 Jun 7. doi: 10.1097/QAI.0000000000001468.
    >> Share

  115. NEWMAN OWIREDU M, Bellare NB, Chakanyuka Musanhu CC, Oyelade TA, et al
    Building Health System Capacity Through Implementation Research: Experience of INSPIRE-A Multi-country PMTCT Implementation Research Project.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S240-S247.
    >> Share

  116. MCCARTHY E, Joseph J, Foster G, Mangwiro AZ, et al
    Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S233-S239.
    >> Share

  117. CATALDO F, Sam-Agudu NA, Phiri S, Shumba B, et al
    The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S224-S232.
    >> Share

  118. ORNE-GLIEMANN J, Font H, Maphosa T, Kangwende A, et al
    Patterns of Attendance at Mother Support Groups in Zimbabwe. The EPAZ Trial (2014-2016).
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S216-S223.
    >> Share

  119. FOSTER G, Orne-Gliemann J, Font H, Kangwende A, et al
    Impact of Facility-Based Mother Support Groups on Retention in Care and PMTCT Outcomes in Rural Zimbabwe: The EPAZ Cluster-Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S207-S215.
    >> Share

  120. ERLWANGER AS, Joseph J, Gotora T, Muzunze B, et al
    Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S198-S206.
    >> Share

  121. JOSEPH J, Gotora T, Erlwanger AS, Mushavi A, et al
    Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S190-S197.
    >> Share

  122. SAM-AGUDU NA, Ramadhani HO, Isah C, Erekaha S, et al
    The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S182-S189.
    >> Share

  123. SAM-AGUDU NA, Ramadhani HO, Isah C, Anaba U, et al
    The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S173-S181.
    >> Share

  124. OSIBO B, Oronsaye F, Alo OD, Phillips A, et al
    Using Small Tests of Change to Improve PMTCT Services in Northern Nigeria: Experiences From Implementation of a Continuous Quality Improvement and Breakthrough Series Program.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S165-S172.
    >> Share

  125. OYELEDUN B, Phillips A, Oronsaye F, Alo OD, et al
    The Effect of a Continuous Quality Improvement Intervention on Retention-In-Care at 6 Months Postpartum in a PMTCT Program in Northern Nigeria: Results of a Cluster Randomized Controlled Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S156-S164.
    >> Share

  126. HOSSEINIPOUR M, Nelson JAE, Trapence C, Rutstein SE, et al
    Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S149-S155.
    >> Share

  127. PHIRI S, Tweya H, van Lettow M, Rosenberg NE, et al
    Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi's Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi).
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S140-S148.
    >> Share

  128. GUNDA A, Jousset A, Tchereni T, Joseph J, et al
    Integrating HIV and Maternal, Neonatal and Child Health Services in Rural Malawi: An Evaluation of the Implementation Processes and Challenges.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S132-S139.
    >> Share

  129. MWAPASA V, Joseph J, Tchereni T, Jousset A, et al
    Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S123-S131.
    >> Share

  130. MYER L, Phillips TK
    Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S115-S122.
    >> Share

  131. ROLLINS NC, Essajee SM, Bellare N, Doherty M, et al
    Improving Retention in Care Among Pregnant Women and Mothers Living With HIV: Lessons From INSPIRE and Implications for Future WHO Guidance and Monitoring.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S111-S114.
    >> Share

  132. BLAIS P, Sirivar S, Seto J
    Supporting Implementation Research to Improve Coverage and Uptake of HIV Related Interventions.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 2:S109-S110.
    >> Share

  133. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand.
    J Acquir Immune Defic Syndr. 2017;75:219-225.
    >> Share

  134. LUI G, Ma RCW, Chook P, Wong CK, et al
    Brief Report: Progression of Atherosclerosis in HIV-Infected Individuals-Prospective Data From an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017;75:198-202.
    >> Share

  135. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017;75:175-183.
    >> Share

    May 2017
  136. ZHANG ZN, Yi N, Zhang TW, Zhang LL, et al
    Myeloid-Derived Suppressor Cells Associated with Disease Progression in Primary HIV Infection: PD-L1 Blockade Attenuates Inhibition.
    J Acquir Immune Defic Syndr. 2017 May 31. doi: 10.1097/QAI.0000000000001471.
    >> Share

  137. BALKUS JE, Palanee-Phillips T, Reddy K, Siva S, et al
    Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception.
    J Acquir Immune Defic Syndr. 2017 May 23. doi: 10.1097/QAI.0000000000001455.
    >> Share

  138. STEVENS WS, Gous NM, MacLeod WB, Long LC, et al
    Manuscript title: Multidisciplinary Point of Care testing in South African primary healthcare clinics accelerates HIV ART initiation but does not alter retention in care.
    J Acquir Immune Defic Syndr. 2017 May 23. doi: 10.1097/QAI.0000000000001456.
    >> Share

  139. VARIAVA E, Sigauke FR, Norman J, Rakgokong M, et al
    Late efavirenz-induced ataxia and encephalopathy: a case series.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001451.
    >> Share

  140. CHAWANA TD, Gandhi M, Nathoo K, Ngara B, et al
    Defining a cut-off for atazanavir in hair samples associated with virological failure among adolescents failing second-line antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001452.
    >> Share

  141. KELLY SG, Krueger KM, Grant JL, Penugonda S, et al
    Statin prescribing practices in the comprehensive care for HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001454.
    >> Share

  142. BROWN SA, Abbas S, Davies MA, Bunupuradah T, et al
    Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001453.
    >> Share

  143. DROZD DR, Kitahata MM, Althoff KN, Zhang J, et al
    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001450.
    >> Share

  144. TSAI YT, Chen YC, Hsieh CY, Ko WC, et al
    Incidence of Neurological Disorders among HIV-Infected Individuals with Universal Health Care in Taiwan, 2000 through 2010.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001448.
    >> Share

  145. AMEH S, Klipstein-Grobusch K, Musenge E, Kahn K, et al
    Effectiveness of an Integrated Approach to HIV and Hypertension Care in Rural South Africa: Controlled Interrupted Time-Series Analysis.
    J Acquir Immune Defic Syndr. 2017 May 16. doi: 10.1097/QAI.0000000000001437.
    >> Share

  146. CRESSEY TR, Punyawudho B, Le Coeur S, Jourdain G, et al
    Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates.
    J Acquir Immune Defic Syndr. 2017 May 9. doi: 10.1097/QAI.0000000000001447.
    >> Share

  147. VUJKOVIC M, Bellamy SL, Zuppa AF, Gastonguay M, et al
    CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-treated HIV-Infected Patients in Botswana.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001442.
    >> Share

  148. CHEN YH, McFarland W, Raymond HF, Scott HM, et al
    Distribution of behavioral patterns prior to infection among San Francisco men who have sex with men newly infected with HIV in 2014.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001439.
    >> Share

  149. MALEE KM, Chernoff MC, Sirois PA, Williams PL, et al
    Impact of Perinatally Acquired HIV Disease Upon Longitudinal Changes in Memory and Executive Functioning.
    J Acquir Immune Defic Syndr. 2017 May 5. doi: 10.1097/QAI.0000000000001441.
    >> Share

  150. LUAN H, Han X, Yu X, An M, et al
    Dual infection contributes to rapid disease progression in men who have sex with men in China.
    J Acquir Immune Defic Syndr. 2017 May 2. doi: 10.1097/QAI.0000000000001420.
    >> Share

  151. IZZO I, Quiros-Roldan E, Casari S, Gargiulo F, et al
    Characteristics and Outcome of a Cohort of HIV-1 Non-B Subtype-Infected Patients After a 10-Year Follow-up Period: A Single Centre Experience.
    J Acquir Immune Defic Syndr. 2017;75:e23-e24.
    >> Share

  152. PATEL RC, Baeten JM, Heffron R, Hong T, et al
    Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    J Acquir Immune Defic Syndr. 2017;75:91-96.
    >> Share

  153. GOOSBY E, Abrams E, Bekker LG, Mushavi A, et al
    Crossing the Finish Line.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S106-S107.
    >> Share

  154. VITILLO RJ, Merico F, Levine AS, Buonocore T, et al
    A Comprehensive Response: The Role of Nonstate Actors in the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S99-S105.
    >> Share

  155. LYONS C, Pillay Y
    Understanding the Role and Impact of Effective Country and Community Leadership in Progress Toward the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S94-S98.
    >> Share

  156. MATHESON R, Brion S, Sharma A, Dilmitis S, et al
    Realizing the Promise of the Global Plan: Engaging Communities and Promoting the Health and Human Rights of Women Living With HIV.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S86-S93.
    >> Share

  157. MODI S, Callahan T, Rodrigues J, Kajoka MD, et al
    Overcoming Health System Challenges for Women and Children Living With HIV Through the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S76-S85.
    >> Share

  158. RADIN AK, Abutu AA, Okwero MA, Adler MR, et al
    Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S66-S75.
    >> Share

  159. PENAZZATO M, Amzel A, Abrams EJ, Kiragu K, et al
    Pediatric Treatment Scale-Up: The Unfinished Agenda of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S59-S65.
    >> Share

  160. ESSAJEE S, Bhairavabhotla R, Penazzato M, Kiragu K, et al
    Scale-up of Early Infant HIV Diagnosis and Improving Access to Pediatric HIV Care in Global Plan Countries: Past and Future Perspectives.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S51-S58.
    >> Share

  161. KALUA T, Tippett Barr BA, van Oosterhout JJ, Mbori-Ngacha D, et al
    Lessons Learned From Option B+ in the Evolution Toward "Test and Start" From Malawi, Cameroon, and the United Republic of Tanzania.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S43-S50.
    >> Share

  162. KIRAGU K, Collins L, Von Zinkernagel D, Mushavi A, et al
    Integrating PMTCT Into Maternal, Newborn, and Child Health and Related Services: Experiences From the Global Plan Priority Countries.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S36-S42.
    >> Share

  163. HAMILTON E, Bossiky B, Ditekemena J, Esiru G, et al
    Using the PMTCT Cascade to Accelerate Achievement of the Global Plan Goals.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S27-S35.
    >> Share

  164. ABDOOL KARIM Q, Baxter C, Birx D
    Prevention of HIV in Adolescent Girls and Young Women: Key to an AIDS-Free Generation.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S17-S26.
    >> Share

  165. LUO C, Hirnschall G, Rodrigues J, Romano S, et al
    Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan Era.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S7-S16.
    >> Share

  166. HAROZ D, von Zinkernagel D, Kiragu K
    Development and Impact of the Global Plan.
    J Acquir Immune Defic Syndr. 2017;75 Suppl 1:S2-S6.
    >> Share

  167. O'NEILL TJ, Djiometio Nguemo J, Tynan AM, Burchell AN, et al
    Risk Of Colorectal Cancer And Associated Mortality In Hiv: A Systematic Review And Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 May 1. doi: 10.1097/QAI.0000000000001433.
    >> Share

    April 2017
  168. GONSALVES GS, Paltiel AD, Cleary PD, Gill MJ, et al
    A Flow-Based Model of the HIV Care Continuum in the United States.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001429.
    >> Share

  169. HOFFMANN CJ, Mabuto T, Ginindza S, Fielding KL, et al
    Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation Following HIV Diagnosis: a Randomized Trial.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001428.
    >> Share

  170. FOGEL JM, Piwowar-Manning E, Debevec B, Walsky T, et al
    Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001421.
    >> Share

  171. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Changing dynamics of HIV transmission in Cote d'Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976-2015).
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001434.
    >> Share

  172. POWELL AM, DeVita JM, Ogburu-Ogbonnaya A, Peterson A, et al
    The effect of HIV-centered obstetric care on perinatal outcomes among a cohort of women living with HIV.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001432.
    >> Share

  173. SACDALAN C, Crowell TA, Colby DJ, Kroon E, et al
    Brief Report: Safety of frequent blood sampling in research participants in an acute HIV infection cohort in Thailand.
    J Acquir Immune Defic Syndr. 2017 Apr 26. doi: 10.1097/QAI.0000000000001436.
    >> Share

  174. YEN YF, Jen IA, Chen M, Lan YC, et al
    Human Immunodeficiency Virus Infection Increases the Risk of Incident Psoriasis: A Nationwide Population-based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001431.
    >> Share

  175. LIU T, Hogan JW, Daniels MJ, Coetzer M, et al
    Improved HIV-1 Viral Load Monitoring Capacity using Pooled Testing with Marker-Assisted Deconvolution.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001424.
    >> Share

  176. BEER L, Mattson CL, Bradley H, Shouse RL, et al
    Trends in ART prescription and viral suppression among HIV-positive young adults in care in the United States, 2009-2013.
    J Acquir Immune Defic Syndr. 2017 Apr 25. doi: 10.1097/QAI.0000000000001427.
    >> Share

  177. ROSENBERG NE, Graybill LA, Wesevich A, McGrath N, et al
    The Impact of Couple HIV Testing and Counseling on Consistent Condom Use among Pregnant Women and their Male Partners: An Observational Study.
    J Acquir Immune Defic Syndr. 2017 Apr 18. doi: 10.1097/QAI.0000000000001398.
    >> Share

  178. PUHR R, Kumarasamy N, Ly PS, Ng OT, et al
    HIV and Aging: Demographic Change in the Asia-Pacific Region.
    J Acquir Immune Defic Syndr. 2017;74:e146-e148.
    >> Share

  179. GWADZ M, Cleland CM, Perlman DC, Hagan H, et al
    Public Health Benefit of Peer-Referral Strategies for Detecting Undiagnosed HIV Infection Among High-Risk Heterosexuals in New York City.
    J Acquir Immune Defic Syndr. 2017;74:499-507.
    >> Share

  180. KELLY JD, Reid MJ, Lahiff M, Tsai AC, et al
    Community-level HIV stigma as a driver for HIV transmission risk behaviors and sexually transmitted diseases in Sierra Leone: a population-based study.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001418.
    >> Share

  181. NAIKOBA S, Senjovu KD, Mugabe P, McCarthy C, et al
    Improved HIV and TB knowledge and competence among mid-level providers in a cluster-randomized trial of one-on-one mentorship for task-shifting.
    J Acquir Immune Defic Syndr. 2017 Apr 12. doi: 10.1097/QAI.0000000000001378.
    >> Share

  182. XIA Q, Zhong Y, Wiewel EW, Braunstein SL, et al
    Linkage to Care after HIV Diagnosis in New York City: Better Than We Thought.
    J Acquir Immune Defic Syndr. 2017 Apr 10. doi: 10.1097/QAI.0000000000001419.
    >> Share

  183. PERKINS M, Bradley W, Lalani T, Agan B, et al
    Prevalence of Post-Treatment Controller Phenotype is Rare in HIV-infected Persons after Stopping Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001393.
    >> Share

  184. DUBROW R, Qin L, Lin H, Hernandez-Ramirez RU, et al
    Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001394.
    >> Share

  185. RIDOLFO AL, Oreni L, Vassalini P, Resnati C, et al
    Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan Italy.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001388.
    >> Share

  186. GUERRI-FERNANDEZ R, Molina-Morant D, Villar-Garcia J, Herrera S, et al
    Bone density, microarchitecture and tissue quality following long-term treatment with tenofovir/emtricitabine or abacavir/lamivudine.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001396.
    >> Share

  187. MONTEJANO R, Stella-Ascariz N, Monge S, Bernardino JI, et al
    Impact of antiretroviral treatment containing tenofovir difumarate on the telomere length of aviremic HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001391.
    >> Share

  188. CASETTI R, Pinnetti C, Sacchi A, De Simone G, et al
    HIV-specific CD8 T cells producing CCL-4 are associated with worse immune reconstitution during chronic infection.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001392.
    >> Share

  189. GAIST P, Stirratt MJ
    The Roles of Behavioral and Social Science Research in the Fight against HIV/AIDS: A Functional Framework.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001399.
    >> Share

  190. MALLAMPATI D, Ford N, Hanaford A, Sugandhi N, et al
    Performance of virological testing for early infant diagnosis: A systematic review.
    J Acquir Immune Defic Syndr. 2017 Apr 7. doi: 10.1097/QAI.0000000000001387.
    >> Share

  191. BROWN LB, Ayieko J, Mwangwa F, Owaraganise A, et al
    Predictors of retention in HIV care among youth (15-24) in a universal test-and-treat setting in rural Kenya.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001390.
    >> Share

  192. SENA AC, Donovan J, Swygard H, Clymore J, et al
    The North Carolina HIV Bridge Counselor Program: outcomes from a statewide level intervention to link and re-engage HIV-infected persons in care in the South.
    J Acquir Immune Defic Syndr. 2017 Apr 6. doi: 10.1097/QAI.0000000000001389.
    >> Share

  193. PATEL RR, Chan PA, Mena L, Crowley JS, et al
    Time to make the jump: Translating HIV pre-exposure prophylaxis research into real-world public health impact.
    J Acquir Immune Defic Syndr. 2017 Apr 4. doi: 10.1097/QAI.0000000000001386.
    >> Share

  194. HOENIGL M, Braun DL, Kouyos R, Gunthard HF, et al
    Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:e114-e117.
    >> Share

  195. AGSALDA-GARCIA MA, Sithinamsuwan P, Valcour VG, Chalermchai T, et al
    Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2017;74:454-458.
    >> Share

  196. MARGOLICK JB, Bream JH, Martinez-Maza O, Lopez J, et al
    Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2017;74:407-417.
    >> Share

  197. CLOUSE K, Vermund SH, Maskew M, Lurie MN, et al
    Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2017;74:383-389.
    >> Share

  198. PASTOR L, Parker E, Carrillo J, Urrea V, et al
    A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:459-466.
    >> Share

    March 2017
  199. CUNNINGHAM WE, Ford CL, Kinsler JJ, Seiden D, et al
    Effects of a Laboratory Health Information Exchange Intervention on Antiretroviral Therapy Use, Viral Suppression and Racial/Ethnic Disparities.
    J Acquir Immune Defic Syndr. 2017 Mar 25. doi: 10.1097/QAI.0000000000001385.
    >> Share

  200. IBRAHIM M, Moyo S, Mohammed T, Mupfumi L, et al
    High Sensitivity and Specificity of the Cepheid Xpert(R) HIV-1 Qualitative Point-of-Care Test among Newborns in Botswana.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001384.
    >> Share

  201. KOELSCH KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, et al
    Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in three HIV infected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001381.
    >> Share

  202. SCRIVEN JE, Graham LM, Schutz C, Scriba TJ, et al
    The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2017 Mar 24. doi: 10.1097/QAI.0000000000001382.
    >> Share

  203. MADHAVI V, Kulkarni A, Shete A, Lee WS, et al
    Effect of combination antiretroviral therapy on HIV-1-specific antibody-dependent cellular cytotoxicity responses in subtype B- and subtype C-infected cohorts.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001380.
    >> Share

  204. KELESIDIS T, Oda MN, Borja MS, Yee Y, et al
    Predictors of impaired HDL function in HIV-1 infected compared to uninfected individuals.
    J Acquir Immune Defic Syndr. 2017 Mar 23. doi: 10.1097/QAI.0000000000001383.
    >> Share

  205. ZHOU RH, Guo L, Liu JB, Liu H, et al
    Epigallocatechin gallate inhibits macaque SEVI-mediated enhancement of SIV or SHIV infection.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001361.
    >> Share

  206. SIVAY MV, Li M, Piwowar-Manning E, Zhang Y, et al
    Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001374.
    >> Share

  207. LEVINE AJ, Martin E, Sacktor N, Munro C, et al
    Predictors and impact of self-reported suboptimal effort on estimates of prevalence of HIV-associated neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2017 Mar 22. doi: 10.1097/QAI.0000000000001371.
    >> Share

  208. MUKERJI SS, Misra V, Lorenz D, Cervantes-Arslanian AM, et al
    Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001362.
    >> Share

  209. MAHESWARAN H, Petrou S, MacPherson P, Kumwenda F, et al
    Economic costs and health-related quality of life outcomes of HIV treatment following self- and facility-based HIV testing in a cluster randomised trial.
    J Acquir Immune Defic Syndr. 2017 Mar 21. doi: 10.1097/QAI.0000000000001373.
    >> Share

  210. MORGAN E, Nyaku AN, D'Aquila RT, Schneider JA, et al
    Determinants of HIV phylogenetic clustering in Chicago among young black men who have sex with men from the uConnect cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001379.
    >> Share

  211. MERLIN JS, Westfall AO, Heath SL, Goodin BR, et al
    IL-1beta levels are associated with chronic multisite pain in people living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001377.
    >> Share

  212. REID MJ, Baxi SM, Sheira LA, Landay AL, et al
    Higher Body Mass Index is Associated with Greater Proportions of Effector CD8+ T cells Expressing CD57 in Women Living with HIV.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001376.
    >> Share

  213. CEPEDA JA, Solomon SS, Srikrishnan AK, McFall AM, et al
    Injection drug network characteristics are important markers of HIV risk behavior and lack of viral suppression.
    J Acquir Immune Defic Syndr. 2017 Mar 20. doi: 10.1097/QAI.0000000000001372.
    >> Share

  214. LUI G, Ma RC, Chook P, Wong CK, et al
    Progression of Atherosclerosis in HIV-infected Individuals - Prospective Data from an Asian Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001358.
    >> Share

  215. NACHEGA JB, Uthman OA, Mofenson LM, Anderson JR, et al
    Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001359.
    >> Share

  216. TEERAANANCHAI S, Bunupuradah T, Puthanakit T, Kerr SJ, et al
    First line antiretroviral treatment outcomes and durability in HIV-infectedchildren treatedthrough theuniversal coverage health program in Thailand.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001351.
    >> Share

  217. COELHO LE, Ribeiro SR, Japiassu AM, Moreira RI, et al
    30-day readmission rates in an HIV-infected cohort from Rio de Janeiro, Brazil.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001352.
    >> Share

  218. THOMSON KA, Haberer JE, Marzinke M, Mujugira A, et al
    Medication Sharing is Rare among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001356.
    >> Share

  219. TOMITA A, Vandormael AM, Barnighausen T, de Oliveira T, et al
    Social disequilibrium and the risk of HIV acquisition: A multilevel study in rural KwaZulu-Natal Province, South Africa.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001349.
    >> Share

  220. KAHN J, Xu J, Kapogiannis BG, Sleasman JW, et al
    Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001355.
    >> Share

  221. KASAIE P, Pennington J, Shah MS, Berry SA, et al
    The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model.
    J Acquir Immune Defic Syndr. 2017 Mar 10. doi: 10.1097/QAI.0000000000001354.
    >> Share

  222. ARRIBAS JR, Thompson M, Sax PE, Haas B, et al
    A Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil fumarate (TDF), Each Coformulated with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.
    J Acquir Immune Defic Syndr. 2017 Mar 9. doi: 10.1097/QAI.0000000000001350.
    >> Share

  223. HALL EW, Ricca AV, Khosropour CM, Sullivan PS, et al
    Capturing HIV incidence among MSM through at-home and self-reported facility-based testing.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001338.
    >> Share

  224. WOHL DA, Golin CE, Knight K, Gould M, et al
    A Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia Following Prison Release: The imPACT Trial.
    J Acquir Immune Defic Syndr. 2017 Mar 8. doi: 10.1097/QAI.0000000000001337.
    >> Share

  225. RAFFI F, Orkin C, Clarke A, Slama L, et al
    Long-term (96-week) Efficacy and Safety After Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) in HIV-infected, Virologically Suppressed Adults.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001344.
    >> Share

  226. LACOMBE K, Fontaine H, Dhiver C, Metivier S, et al
    Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Co-Infected Patients With Advanced Liver Disease in a French Early-Access Cohort.
    J Acquir Immune Defic Syndr. 2017 Mar 6. doi: 10.1097/QAI.0000000000001342.
    >> Share

  227. VAN HANDEL MM, Brooks JT
    Reply.
    J Acquir Immune Defic Syndr. 2017;74:e84-e85.
    >> Share

  228. BOYLES TH, Gatley E, Wasserman S, Meintjes G, et al
    Brief Report: Flow Rate of Cerebrospinal Fluid Through a Spinal Needle Can Accurately Predict Intracranial Pressure in Cryptococcal Meningitis.
    J Acquir Immune Defic Syndr. 2017;74:e64-e66.
    >> Share

  229. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital-Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women.
    J Acquir Immune Defic Syndr. 2017;74:318-325.
    >> Share

  230. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV Pre-Exposure Prophylaxis (PrEP) in a National Cohort of Gay and Bisexual Men in the United States.
    J Acquir Immune Defic Syndr. 2017;74:285-292.
    >> Share

    February 2017
  231. CARLUCCI JG, Blevins M, Kipp AM, Lindegren ML, et al
    Tuberculosis Treatment Outcomes among HIV/TB Co-Infected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001335.
    >> Share

  232. HERNANDEZ S, Catalan-Garcia M, Moren C, Garcia-Otero L, et al
    Placental Mitochondrial Toxicity, Oxidative Stress, Apoptosis And Adverse Perinatal Outcomes In Hiv-Pregnancies Under Antiretroviral Treatment Containing Zidovudine.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001334.
    >> Share

  233. MUSARANDEGA R, Machekano R, Chideme M, Muchuchuti C, et al
    PMTCT Service Uptake among Adolescents and Adult Women Attending Antenatal Care in Selected Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001327.
    >> Share

  234. RAY N, Li T, Lin Z, Protack T, et al
    The second-generation maturation inhibitor GSK3532795 maintains potent activity toward HIV protease inhibitor-resistant clinical isolates.
    J Acquir Immune Defic Syndr. 2017 Feb 20. doi: 10.1097/QAI.0000000000001304.
    >> Share

  235. HELMUT A, Dillingham R, Hogg RS, Jaworsky D, et al
    The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
    J Acquir Immune Defic Syndr. 2017 Feb 16. doi: 10.1097/QAI.0000000000001329.
    >> Share

  236. XIA Q, Sun X, Wiewel EW, Torian LV, et al
    HIV Prevalence and the Prevalence of Unsuppressed HIV in New York City, 2010-2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001311.
    >> Share

  237. SINGH D, Ghate M, Godbole S, Kulkarni S, et al
    CD1d restricted Natural killer T cells are preserved in Indian long term non progressors (LTNPs).
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001322.
    >> Share

  238. MACATANGAY BJ, Yang M, Sun X, Morton J, et al
    Changes in Levels of Inflammation Following Antiretroviral Treatment During Early HIV Infection in ACTG A5217.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001320.
    >> Share

  239. BRUNET L, Napravnik S, Heine AD, Leone PA, et al
    Longitudinal opioid use among HIV-infected patients, 2000 to 2014.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001321.
    >> Share

  240. HAALAND RE, Holder A, Pau CP, Swaims-Kohlmeier A, et al
    Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral TruvadaTM for HIV pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001324.
    >> Share

  241. GALLANT JE, Thompson M, DeJesus E, Voskuhl GW, et al
    Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults.
    J Acquir Immune Defic Syndr. 2017 Feb 8. doi: 10.1097/QAI.0000000000001306.
    >> Share

  242. GIRARD A, Jelicic K, Van Ryk D, Rochereau N, et al
    The neutralizing and targeting properties of a new set of alpha4beta7-specific antibodies are influenced by their isotype.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001307.
    >> Share

  243. KESSING CF, Spudich S, Valcour V, Cartwright P, et al
    High Number of Activated CD8+ T Cells Targeting HIV Antigens are Present in Cerebrospinal Fluid in Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001301.
    >> Share

  244. O'NEILL TJ, Raboud JM, Tinmouth J, Rourke SB, et al
    Gastrointestinal Symptom Distress is Associated with Worse Mental and Physical Health Related Quality of Life.
    J Acquir Immune Defic Syndr. 2017 Feb 7. doi: 10.1097/QAI.0000000000001309.
    >> Share

  245. TENFORDE MW, Yadav A, Dowdy DW, Gupte N, et al
    Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001308.
    >> Share

  246. BRAHMBHATT H, Boivin M, Ssempijja V, Kagaayi J, et al
    Impact of HIV and Atiretroviral Therapy on Neurocognitive Outcomes Among School Aged Children.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001305.
    >> Share

  247. LYONS C, Ketende S, Drame F, Grosso A, et al
    Physical and sexual violence affecting female sex workers in Abidjan, Cote d'Ivoire: Prevalence, and the relationship between violence, the work environment, HIV and access to health services.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001310.
    >> Share

  248. WOHL AR, Ludwig-Barron N, Dierst-Davies R, Kulkarni S, et al
    Project Engage: Snowball Sampling and Direct Recruitment to Identify and Link Hard-to-Reach HIV-Infected Persons who are Out of Care.
    J Acquir Immune Defic Syndr. 2017 Feb 6. doi: 10.1097/QAI.0000000000001312.
    >> Share

  249. YOUNG SD, Yu W, Wang W
    Toward Automating HIV Identification: Machine Learning for Rapid Identification of HIV-Related Social Media Data.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S128-S131.
    >> Share

  250. SENN TE, Braksmajer A, Coury-Doniger P, Urban MA, et al
    Development and Preliminary Pilot Testing of a Peer Support Text Messaging Intervention for HIV-Infected Black Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S121-S127.
    >> Share

  251. COLASANTI J, Stahl N, Farber EW, Del Rio C, et al
    An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S113-S120.
    >> Share

  252. DOLWICK GRIEB SM, Flores-Miller A, Page KR
    inverted exclamation markSolo Se Vive Una Vez! (You Only Live Once): A Pilot Evaluation of Individually Tailored Video Modules Aiming to Increase HIV Testing Among Foreign-Born Latino Men.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S104-S112.
    >> Share

  253. CASTEL AD, Kuo I, Mikre M, Young T, et al
    Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S96-S103.
    >> Share

  254. POWERS KA, Samoff E, Weaver MA, Sampson LA, et al
    Longitudinal HIV Care Trajectories in North Carolina.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S88-S95.
    >> Share

  255. DOMBROWSKI JC, Bove J, Roscoe JC, Harvill J, et al
    "Out of Care" HIV Case Investigations: A Collaborative Analysis Across 6 States in the Northwest US.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S81-S87.
    >> Share

  256. GREENBERG AE, Gordon CM, Purcell DW
    Promotion of Research on the HIV Continuum of Care in the United States: The CFAR HIV Continuum of Care/ECHPP Working Group.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 2:S75-S80.
    >> Share

  257. SCHNELL KM, Atta MG, Fine DM, Zook K, et al
    Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications.
    J Acquir Immune Defic Syndr. 2017 Feb 1. doi: 10.1097/QAI.0000000000001302.
    >> Share

    January 2017
  258. GOEIEMAN BJ, Firnhaber CS, Jong E, Michelow P, et al
    Prevalence Of Anal Hpv And Anal Dysplasia In Hiv-Infected Women From Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001300.
    >> Share

  259. LACOURSE SM, Cranmer LM, Matemo D, Kinuthia J, et al
    Effect of pregnancy on interferon gamma release-assay and tuberculin skin test detection of latent TB infection among HIV-infected women in a high burden setting.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001298.
    >> Share

  260. RUBIN LH, Phan KL, Keating SM, Weber KM, et al
    Low dose hydrocortisone has acute enhancing effects on verbal learning in HIV-infected men.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001303.
    >> Share

  261. FELSEN UR, Cunningham CO, Heo M, Futterman DC, et al
    An expanded HIV testing strategy leveraging the electronic medical record uncovers undiagnosed infection among hospitalized patients.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001299.
    >> Share

  262. WALKER JA, Miller AD, Burdo TH, McGrath MS, et al
    Direct Targeting of Macrophages with Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology.
    J Acquir Immune Defic Syndr. 2017 Jan 30. doi: 10.1097/QAI.0000000000001297.
    >> Share

  263. DE LA MATA NL, Ly PS, Van Nguyen K, Merati TP, et al
    Loss to follow-up trends in HIV-positive patients receiving antiretroviral treatment in Asia from 2003 to 2013.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001293.
    >> Share

  264. SAPHONN V, Fujita M, Samreth S, Chan S, et al
    Cluster of HIV Infections Associated with Unsafe Injection Practices in a Rural Village in Cambodia.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001295.
    >> Share

  265. SANFORD R, Fernandez Cruz AL, Scott SC, Mayo NE, et al
    Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-infected Patients in the HAART era.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001294.
    >> Share

  266. KITYO C, Thompson J, Nankya I, Hoppe A, et al
    HIV drug resistance mutations in non-B subtypes after prolonged virological failure on NNRTI-based first-line regimens in sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2017 Jan 25. doi: 10.1097/QAI.0000000000001285.
    >> Share

  267. LAU E, Brophy J, Samson L, Kakkar F, et al
    Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001291.
    >> Share

  268. BEIMA-SOFIE KM, Brandt L, Hamunime N, Shepard M, et al
    Pediatric HIV disclosure intervention improves knowledge and clinical outcomes in HIV-infected children in Namibia.
    J Acquir Immune Defic Syndr. 2017 Jan 20. doi: 10.1097/QAI.0000000000001290.
    >> Share

  269. COUDERC C, Keita BD, Anoma C, Wade AS, et al
    Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multi-country cohort.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001288.
    >> Share

  270. MASIA M, Padilla S, Fernandez M, Barber X, et al
    Contribution of oxidative stress to non-AIDS events in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001287.
    >> Share

  271. WOLDESENBET S, Jackson DJ, Lombard CJ, Dinh TH, et al
    Structural Level Differences in the Mother-to-Child HIV Transmission Rate in South Africa: A Multilevel Assessment of Individual-, Health facility-, and Provincial- Level Predictors of Infant HIV Transmission.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001289.
    >> Share

  272. OKUKU F, Krantz EM, Kafeero J, Kamya MR, et al
    Evaluation of a predictive staging model for HIV-associated Kaposi sarcoma in Uganda.
    J Acquir Immune Defic Syndr. 2017 Jan 18. doi: 10.1097/QAI.0000000000001286.
    >> Share

  273. JONGBLOED-DE HOON M, Colbers A, Velthoven-Graafland K, Duisenberg-van Essenberg M, et al
    Pharmacokinetics of Crushed Elvitegravir Combination Tablet Given with or without Enteral Nutrition.
    J Acquir Immune Defic Syndr. 2017 Jan 3. doi: 10.1097/QAI.0000000000001296.
    >> Share

  274. TUMINO N, Bilotta MT, Pinnetti C, Ammassari A, et al
    Granulocytic Myeloid Derived Suppressor Cells increased in early phases of primary HIV infection depending on TRAIL plasma level.
    J Acquir Immune Defic Syndr. 2017 Jan 2. doi: 10.1097/QAI.0000000000001283.
    >> Share

  275. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S69-S73.
    >> Share

  276. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S60-S68.
    >> Share

  277. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S52-S59.
    >> Share

  278. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S44-S51.
    >> Share

  279. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S37-S43.
    >> Share

  280. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S29-S36.
    >> Share

  281. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S23-S28.
    >> Share

  282. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S15-S22.
    >> Share

  283. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S5-S14.
    >> Share

  284. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S1-S4.
    >> Share

  285. SEGHATOL-ESLAMI VC, Dark HE, Raper JL, Mugavero MJ, et al
    Brief Report: Interpersonal and Intrapersonal Factors as Parallel Independent Mediators in the Association Between Internalized HIV Stigma and ART Adherence.
    J Acquir Immune Defic Syndr. 2017;74:e18-e22.
    >> Share

  286. ROSENBERG MS, Gomez-Olive FX, Rohr JK, Houle BC, et al
    Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74:e9-e17.
    >> Share

  287. ORR N, Hajiyiannis H, Myers L, Makhubele MB, et al
    Development of a National Campaign Addressing South African Men's Fears About HIV Counseling and Testing and Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S69-S73.
    >> Share

  288. KERRIGAN D, Mbwambo J, Likindikoki S, Beckham S, et al
    Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S60-S68.
    >> Share

  289. LYONS CE, Ketende S, Diouf D, Drame FM, et al
    Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S52-S59.
    >> Share

  290. LIPPMAN SA, Neilands TB, MacPhail C, Peacock D, et al
    Community Mobilization for HIV Testing Uptake: Results From a Community Randomized Trial of a Theory-Based Intervention in Rural South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S44-S51.
    >> Share

  291. HIRSCH-MOVERMAN Y, Daftary A, Yuengling KA, Saito S, et al
    Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient-Provider Communication in the START Study.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S37-S43.
    >> Share

  292. SUTTON R, Lahuerta M, Abacassamo F, Ahoua L, et al
    Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S29-S36.
    >> Share

  293. MABUTO T, Charalambous S, Hoffmann CJ
    Effective Interpersonal Health Communication for Linkage to Care After HIV Diagnosis in South Africa.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S23-S28.
    >> Share

  294. MORTON JF, Celum C, Njoroge J, Nakyanzi A, et al
    Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S15-S22.
    >> Share

  295. BABALOLA S, Van Lith LM, Mallalieu EC, Packman ZR, et al
    A Framework for Health Communication Across the HIV Treatment Continuum.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S5-S14.
    >> Share

  296. VERMUND SH, Mallalieu EC, Van Lith LM, Struthers HE, et al
    Health Communication and the HIV Continuum of Care.
    J Acquir Immune Defic Syndr. 2017;74 Suppl 6:S1-S4.
    >> Share

    December 2016
  297. BASSETT IV, Coleman SM, Giddy J, MFamMed, et al
    Barriers to care and 1-year mortality among newly-diagnosed HIV-infected people in Durban, South Africa.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001277.
    >> Share

  298. GOYETTE MS, Wilson KS, Deya R, Masese LN, et al
    Association between menopause and unprotected sex in high-risk HIV-positive women in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2016 Dec 30. doi: 10.1097/QAI.0000000000001282.
    >> Share

  299. HILEMAN CO, Tangpricha V, Sattar A, McComsey GA, et al
    Baseline vitamin D deficiency decreases the effectiveness of statins in HIV-infected adults on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016 Dec 29. doi: 10.1097/QAI.0000000000001281.
    >> Share

  300. KILLIAN MS, Fujimura SH, Sudhagoni RG
    Increased Expression of the Type I Interferon Receptor on CD4+ T Lymphocytes in HIV-1 Infected Individuals.
    J Acquir Immune Defic Syndr. 2016 Dec 22. doi: 10.1097/QAI.0000000000001280.
    >> Share

  301. WEINBERGER AH, Smith PH, Funk AP, Rabin S, et al
    Gender differences in tobacco use among persons living with HIV/AIDS: A systematic review and meta-analysis.
    J Acquir Immune Defic Syndr. 2016 Dec 20. doi: 10.1097/QAI.0000000000001279.
    >> Share

  302. WEISER J, Brooks JT, Skarbinski J, West BT, et al
    Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001276.
    >> Share

  303. SCHMITZ ME, Agolory S, Junghae M, Broyles LN, et al
    Field evaluation of Dried Blood Spots for HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Kenya: Implications for scale-up in resource-limited settings.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001275.
    >> Share

  304. HOTTON AL, Weber KM, Hershow RC, Anastos K, et al
    Prevalence and predictors of hospitalizations among HIV-Infected and at-risk HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016 Dec 17. doi: 10.1097/QAI.0000000000001278.
    >> Share

  305. LANE T, Osmand T, Marr A, Struthers H, et al
    Brief Report: High HIV Incidence in a South African Community of Men Who Have Sex With Men: Results From the Mpumalanga Men's Study, 2012-2015.
    J Acquir Immune Defic Syndr. 2016;73:609-611.
    >> Share

  306. MARCUS JL, Hurley LB, Hare CB, Nguyen DP, et al
    Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
    J Acquir Immune Defic Syndr. 2016;73:540-546.
    >> Share

  307. GILLIS J, Loutfy M, Bayoumi AM, Antoniou T, et al
    A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:531-539.
    >> Share

  308. BOCK P, James A, Nikuze A, Peton N, et al
    Baseline CD4 Count and Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2016;73:514-521.
    >> Share

  309. WAGNER AD, Mugo C, Njuguna IN, Maleche-Obimbo E, et al
    Implementation and Operational Research: Active Referral of Children of HIV-Positive Adults Reveals High Prevalence of Undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016;73:e83-e89.
    >> Share

  310. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016;73:606-608.
    >> Share

  311. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016;73:589-597.
    >> Share

  312. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breastmilk Viral Load: Impacts of Adherence on Peripartum HIV Infections Averted-The Breastfeeding, Antiretrovirals, and Nutrition Study.
    J Acquir Immune Defic Syndr. 2016;73:572-580.
    >> Share

  313. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    Implementation and Operational Research: An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016;73:e67-e75.
    >> Share

  314. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to Primary Care and Survival After Hospital Discharge for HIV-Infected Adults in Tanzania: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2016;73:522-530.
    >> Share

  315. VOGT F, Rehman AM, Kranzer K, Nyathi M, et al
    Relationship between time to initiation of antiretroviral therapy and treatment outcomes: a cohort analysis of ART eligible adolescents in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016 Dec 15. doi: 10.1097/QAI.0000000000001274.
    >> Share

  316. CATALDO F, Chiwaula L, Nkhata M, van Lettow M, et al
    Exploring the experiences of women and health care workers in the context of PMTCT Option B Plus in Malawi.
    J Acquir Immune Defic Syndr. 2016 Dec 9. doi: 10.1097/QAI.0000000000001273.
    >> Share

  317. LUCIA P, Erica P, Jorge C, Victor U, et al
    A cytokine pattern that differentiates pre- from post- seroconversion phases of primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  318. FETTIPLACE A, Stainsby C, Winston A, Givens N, et al
    Psychiatric Symptoms in Patients Receiving Dolutegravir.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  319. NAGAO A, Hanabusa H
    The impact of ledipasvir/sofosbuvir on HIV-positive and HIV-negative Japanese hemophilia patients with 1, 4, and mixed-genotype HCV.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  320. DEREN S, Cleland CM, Lee H, Mehandru S, et al
    The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  321. KENDALL CE, Chalifoux M, Manuel D, Reinhard R, et al
    A population-based study of care at the end of life among people with HIV in Ontario from 2010 to 2013.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  322. FORD D, Muzambi M, Nkhata MJ, Abongomera G, et al
    Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  323. KHOSROPOUR CM, Dombrowski JC, Kerani RP, Katz DA, et al
    Changes in Condomless Sex and Serosorting Among Men Who Have Sex With Men After HIV Diagnosis.
    J Acquir Immune Defic Syndr. 2016;73:475-481.
    >> Share

  324. CHIU A, Modi S, Rivadeneira ED, Koumans EH, et al
    Optimizing Infant HIV Diagnosis in Resource-Limited Settings: Modeling the Impact of HIV DNA PCR Testing at Birth.
    J Acquir Immune Defic Syndr. 2016;73:454-462.
    >> Share

  325. SHARMA A, Ma Y, Scherzer R, Wheeler AL, et al
    Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women.
    J Acquir Immune Defic Syndr. 2016;73:433-437.
    >> Share

  326. PELTENBURG NC, Leers MP, Bakker JA, Lowe SH, et al
    Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016;73:390-395.
    >> Share

  327. SONG R, Pace C, Seaman MS, Fang Q, et al
    Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific Antibodies.
    J Acquir Immune Defic Syndr. 2016;73:365-373.
    >> Share

  328. DIERKS P, Wroblewski R, Eberhard JM, Martrus G, et al
    Increased frequency of CD39+ CD56 bright Natural Killer cells in HIV-1 infection correlates with immune activation and disease progression.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  329. COWAN FM, Davey C, Fearon E, Mushati P, et al
    The HIV care cascade among female sex workers in Zimbabwe: results of a population-based survey from the Sisters Antiretroviral therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

    November 2016
  330. VAN HANDEL MM, Brooks JT
    Understanding local context is necessary for HIV and HCV prevention planning.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  331. WOMACK JA, Murphy TE, Bathulapalli H, Akgun KM, et al
    Sleep Disturbance Among HIV Infected and Uninfected Veterans.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  332. MARZEL A, Heinrich H, Schilliger L, Fehr JS, et al
    Prescription of Post-Exposure Prophylaxis for HIV-1 in the emergency room: Correct transmission risk assessment remains challenging.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  333. ABDEL-HAMEED EA, Rouster SD, Zhang X, Chen J, et al
    Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  334. PARSONS JT, Rendina HJ, Lassiter JM, Whitfield TH, et al
    Uptake of HIV pre-exposure prophylaxis (PrEP) in a national cohort of gay and bisexual men in the United States: The Motivational PrEP Cascade.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  335. CHAGOMERANA MB, Miller WC, Pence BW, Hosseinipour MC, et al
    PMTCT Option B+ does not increase preterm birth risk and may prevent extreme prematurity: A retrospective cohort study in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  336. CHOW FC, Li Y, Hu Y, Chan J, et al
    Relationship between HIV infection, antiretroviral therapy, inflammatory markers and cerebrovascular endothelial function among adults in urban China.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  337. CAMLIN CS, Ayadi AM, Kwena ZA, McFarland W, et al
    High Mobility and HIV Prevalence among Female Market Traders in East Africa in 2014.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  338. DAVEY DJ, Beymer M, Roberts CP, Bolan RK, et al
    Differences in Risk Behavior and Demographic Factors between Men who have Sex with Men with Acute and Non-Acute Human Immunodeficiency Virus Infection in a Community-Based Testing Program in Los Angeles.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  339. SAKODA ME, Fazeli PL, Ellis RJ, Jeste DV, et al
    Higher cystatin C levels are associated with neurocognitive impairment in older HIV+ adults.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  340. PROTOPOPESCU C, Carrieri MP, Raffi F, Picard O, et al
    Prolonged viral suppression over a 12-year follow-up of HIV-infected patients: the persistent impact of adherence at 4 months after initiation of combined antiretroviral therapy in the ANRS CO8 APROCO-COPILOTE cohort.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  341. MENDOZA C, Barrington C, Donastorg Y, Perez M, et al
    Violence from a Sexual Partner is Significantly Associated with Poor HIV Care and Treatment Outcomes among Female Sex Workers in the Dominican Republic.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  342. KORHONEN C, Srinivasan S, Huang D, Ko DL, et al
    Semen Bacterial Concentrations and HIV-1 RNA Shedding among HIV-1-Seropositive Kenyan Men.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  343. GO VF, Frangakis C, Le Minh N, Ha TV, et al
    Increased survival among HIV-infected PWID receiving a multi-level HIV risk and stigma reduction intervention: results from a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  344. KAMENJU P, Liu E, Hertzmark E, Spiegelman D, et al
    Complementary Feeding and Diarrhea and Respiratory Infection Among HIV-exposed Tanzanian Infants.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  345. TURNER CM, Santos GM, Arayasirikul S, Wilson EC, et al
    Psychosocial predictors of engagement in sexual risk behavior among trans*female youth ages 16 - 24 years in San Francisco.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  346. DOBLECKI-LEWIS S, Liu A, Feaster D, Cohen SE, et al
    Healthcare Access and PrEP Continuation in San Francisco and Miami Following the U.S. PrEP Demo Project.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  347. FIDLER S, Olson AD, Bucher HC, Fox J, et al
    Virological blips and predictors of post treatment viral control after stopping ART started in Primary HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  348. BRUZZONE B, Caligiuri P, Nigro N, Arcuri C, et al
    In response to Gueudin et al.: Xpert(R) HIV-1 Viral Load assay and VERSANT(R) HIV-1 RNA 1.5 Assay, a performance comparison.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  349. KOSS CA, Natureeba P, Kwarisiima D, Ogena M, et al
    Viral Suppression and Retention in Care up to 5 Years after Initiation of Lifelong ART during Pregnancy (Option B+) in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  350. AL-KINDI SG, Kim CH, Morris SR, Freeman ML, et al
    Elevated Red Cell Distribution Width (RDW) Identifies Elevated Cardiovascular Disease Risk in Patients with HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  351. MONTEIRO DE ALMEIDA S, Kamat R, Cherner M, Umlauf A, et al
    Improving detection of HIV-associated cognitive impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  352. VITA S, Lichtner M, Marchetti G, Mascia C, et al
    Soluble CD163 in CMV Infected and Uninfected subjects on Virologically-Suppressive Antiretroviral therapy in the ICONA cohort.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  353. MONTOYA JL, Iudicello J, Fazeli PL, Hong S, et al
    Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated with Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  354. KINUTHIA J, Richardson BA, Drake AL, Matemo D, et al
    Sexual Behavior and Vaginal Practices during Pregnancy and Postpartum: Implications for HIV Prevention Strategies.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  355. FOGEL JM, Clarke W, Kulich M, Piwowar-Manning E, et al
    Antiretroviral drug use in a cross-sectional population survey in Africa: NIMH Project Accept (HPTN 043).
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  356. FOX J, Tiraboschi JM, Herrera C, Else L, et al
    Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;73:252-257.
    >> Share

  357. XIA Q, Lazar R, Bernard MA, McNamee P, et al
    New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks.
    J Acquir Immune Defic Syndr. 2016;73:e59-e62.
    >> Share

  358. HAINES CF, Fleishman JA, Yehia BR, Lau B, et al
    Closing the Gap in Antiretroviral Initiation and Viral Suppression: Time Trends and Racial Disparities.
    J Acquir Immune Defic Syndr. 2016;73:340-347.
    >> Share

  359. VAN HANDEL MM, Rose CE, Hallisey EJ, Kolling JL, et al
    County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
    J Acquir Immune Defic Syndr. 2016;73:323-331.
    >> Share

  360. LUDEMA C, Cole SR, Eron JJ Jr, Edmonds A, et al
    Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.
    J Acquir Immune Defic Syndr. 2016;73:307-312.
    >> Share

  361. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016;73:e51-e58.
    >> Share

  362. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.
    J Acquir Immune Defic Syndr. 2016;73:e46-e50.
    >> Share

  363. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016;73:e39-e45.
    >> Share

    October 2016
  364. SCHEIM AI, Bauer GR, Travers R
    HIV-related sexual risk among transgender men who are gay, bisexual, or have sex with men.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  365. TAYLOR N, Kremser I, Auer S, Hoermann G, et al
    Hemeoxygenase-1 as a novel driver in ritonavir-induced insulin resistance in HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  366. SHEPHERD BE, Rebeiro PF
    Assessing and interpreting the association between continuous covariates and outcomes in observational studies of HIV using splines.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  367. YEN YF, Chen M, Jen I, Lan YC, et al
    Association of HIV and Opportunistic Infections with Incident Stroke: A Nationwide Population-based Cohort Study in Taiwan.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  368. LIEBENBERG LJ, Masson L, Arnold KB, Mckinnon LR, et al
    Genital - Systemic chemokine gradients and the risk of HIV acquisition in women.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  369. CHOI KH, Steward WT, Miege P, Gregorich SE, et al
    Unpacking the Influence of Sexual Stigma on HIV Risk: Results from a Prospective Study of Men Who Have Sex with Men in Beijing, China.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  370. VOGT F, Kalenga L, Lukela J, Salumu F, et al
    Decentralizing ART supply for stable HIV patients to community-based distribution centres: Programme outcomes from an urban context in Kinshasa, DRC.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  371. YOTEBIENG M, Moracco KE, Thirumurthy H, Edmonds A, et al
    Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  372. GOMEZ-MORA E, Robert-Hebmann V, Garcia E, Massanella M, et al
    Impaired CD4 T-cell response to autophagy in treated HIV-1-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  373. EATON EF, Hudak K, Muzny CA
    Budgetary Impact of Compliance with STI Screening Guidelines in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  374. HARRIS RA, Xue X, Selwyn PA
    Housing Stability and Medication Adherence among HIV-Positive Individuals in Antiretroviral Therapy: A Meta-Analysis of Observational Studies in the U.S.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  375. BAXI SM, Scherzer R, Jotwani V, Estrella MM, et al
    Changes in Urinary Biomarkers over 10 Years is Associated with Viral Suppression in a Prospective Cohort of Women Living with HIV.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  376. KOURTIS AP, Wiener J, King CC, Heffron R, et al
    Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-infected African women.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  377. PIRONTI A, Walter H, Pfeifer N, Knops E, et al
    Determination of Phenotypic Resistance Cutoffs from Routine Clinical Data.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  378. HUHN GD, Tebas P, Gallant J, Wilkin T, et al
    A Randomized , Open-label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide plus Darunavir in Treatment-Experienced HIV-1 Infected Adults.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  379. MANHICA I, Bhatt N, Ismael N, Nhavene E, et al
    First report of prevalence of HTLV-1 among HIV-1/2 infected children in Mozambique.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  380. WINSTON A, Stohr W, Antinori A, Amieva H, et al
    Changes in Cognitive Function Over 96 weeks in Naive Patients Randomised to Darunavir-ritonavir plus either Raltegravir or Tenofovir-Emtricitabine: a substudy of the NEAT001/ANRS143 trial.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  381. SATRE DD, Altschuler A, Parthasarathy S, Silverberg MJ, et al
    Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  382. BALLEGAARD V, Ralfkiaer U, Pedersen KK, Hove M, et al
    MicroRNA-210, microRNA-331 and microRNA-7 are differentially regulated in treated HIV-1-infected individuals, and are associated with markers of systemic inflammation.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  383. SHI B, Li J, Shi X, Jia W, et al
    TALEN-mediated knockout of CCR5 confers protection against infection of human immunodeficiency virus.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  384. JOSEPH DAVEY D, Nhavoto JA, Augusto O, Ponce W, et al
    SMSaude: Evaluating Mobile Phone Text Reminders to Improve Retention in HIV Care for Patients on Antiretroviral Therapy in Mozambique.
    J Acquir Immune Defic Syndr. 2016;73:e23-30.
    >> Share

  385. RANSOME Y, Galea S, Pabayo R, Kawachi I, et al
    Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.
    J Acquir Immune Defic Syndr. 2016;73:213-21.
    >> Share

  386. BASSETT IV, Coleman SM, Giddy J, Bogart LM, et al
    Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa.
    J Acquir Immune Defic Syndr. 2016;73:154-60.
    >> Share

  387. STIKSRUD B, Lorvik KB, Kvale D, Mollnes TE, et al
    Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts.
    J Acquir Immune Defic Syndr. 2016;73:138-48.
    >> Share

    September 2016
  388. LEE SK, Zhou S, Baldoni PL, Spielvogel E, et al
    Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID In A Viral Outgrowth Assay.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  389. POST FA, Tebas P, Clarke A, Cotte L, et al
    Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  390. BOYLES TH, Gately E, Wasserman S, Meintjes G, et al
    Flow rate of CSF through a spinal needle can accurately predict intracranial pressure in cryptococcal meningitis.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  391. BACON O, Gonzalez R, Andrew E, Potter MB, et al
    Informing Strategies to Build PrEP Capacity among San Francisco Bay Area Clinicians.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  392. THOBAKGALE C, Naidoo K, McKinnon LR, Werner L, et al
    Interleukin 1-beta (IL-1beta) production by innate cells following TLR stimulation correlates with TB recurrence in ART-treated HIV infected patients.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  393. XIA Q, Teixeira-Pinto A, Forgione LA, Wiewel EW, et al
    Estimated HIV Incidence in the United States, 2003-2010.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  394. WAGNER AD, Wachira CM, Njuguna IN, Maleche-Obimbo E, et al
    Active referral of children of HIV-positive adults reveals high prevalence of undiagnosed HIV.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  395. HOSEK S, Rudy B, Landovitz R, Kapogiannis B, et al
    An HIV Pre-Exposure Prophylaxis (PrEP) Demonstration Project and Safety Study for Young MSM.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  396. WESTERCAMP M, Jaoko W, Mehta S, Abuor P, et al
    Changes in Male Circumcision Prevalence and Risk Compensation in the Kisumu, Kenya Population 2008-2013.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  397. YU F, Hao Y, Zhao H, Xiao J, et al
    Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells from HIV-infected Patients.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  398. DUFF P, Goldenberg S, Deering K, Montaner J, et al
    Barriers to Viral Suppression Among Female Sex Workers: Role of Structural and Intimate Partner Dynamics.
    J Acquir Immune Defic Syndr. 2016;73:83-90.
    >> Share

  399. KOOIJ KW, Schouten J, Wit FW, van der Valk M, et al
    Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency.
    J Acquir Immune Defic Syndr. 2016;73:55-62.
    >> Share

  400. BRENNAN AT, Long L, Useem J, Garrison L, et al
    Mortality in the First 3 Months on Antiretroviral Therapy Among HIV-Positive Adults in Low- and Middle-income Countries: A Meta-analysis.
    J Acquir Immune Defic Syndr. 2016;73:1-10.
    >> Share

  401. PADAYATCHI N, Naidu N, Yende-Zuma N, O'Donnell MR, et al
    Implementation and Operational Research: Clinical Impact of the Xpert MTB/RIF Assay in Patients With Multidrug-Resistant Tuberculosis.
    J Acquir Immune Defic Syndr. 2016;73:e1-7.
    >> Share

  402. QUISPE CALLA NE, Vicetti Miguel RD, Trout W, Cherpes TL, et al
    HIV and Hormonal Contraception: Bench and Bedside.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  403. RONEN K, McGrath CJ, Langat AC, Kinuthia J, et al
    Gaps in Adolescent Engagement in Antenatal Care and Prevention of Mother-to-Child HIV Transmission Services in Kenya.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  404. GAMELL A, Glass TR, Luwanda LB, Mapesi H, et al
    An Integrated and Comprehensive Service Delivery Model to Improve Pediatric and Maternal HIV Care in Rural Africa.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

    August 2016
  405. PAGANELLA MP, Cohen RA, Harris DR, de Souza Kuchenbecker R, et al
    Association of Dyslipidemia and Glucose Abnormalities with Antiretroviral Treatment in a Cohort of HIV-infected Latin American Children.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  406. FLORIDIA M, Liotta G, Andreotti M, Galluzzo CM, et al
    Serum phosphate and creatinine levels in the first year of life in infants born to HIV-positive mothers receiving tenofovir-based combination regimens during pregnancy and prolonged breastfeeding in an option B+ programme in Malawi.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  407. GUO D, Zhou T, Arainga M, Palandri D, et al
    Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  408. HOLLOWAY I, Dougherty R, Gildner J, Beougher SC, et al
    PrEP Uptake, Adherence, and Discontinuation among California YMSM Using Geosocial Networking Applications.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  409. CANOUI E, Noel N, Lecuroux C, Boufassa F, et al
    Strong Ifitm1 Expression In Cd4 T Cells In Hiv Controllers Is Correlated With Immune Activation.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  410. ELOPRE L, Kudroff K, Westfall AO, Overton ET, et al
    The Right People, Right Places, and Right Practices: Disparities in PrEP access among African American Men, Women and MSM in the Deep South.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  411. SHIN SS, Modongo C, Boyd R, Caiphus C, et al
    High Treatment Success Rates among HIV-infected Multidrug-resistant Tuberculosis Patients after Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  412. CALENDA G, Villegas G, Barnable P, Litterst C, et al
    MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  413. SAAG MS, Westfall AO, Cole SR, Mathews WC, et al
    Factors associated with the selection of initial antiretroviral therapy from 2009 to 2012.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  414. CHETWYND AJ, Samarawickrama A, Vera JH, Bremner SA, et al
    Nanoflow-nanospray mass spectrometry metabolomics reveals disruption of the urinary metabolite profiles of HIV-positive patients on combination antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  415. HANSCOM B, Janes HE, Guarino PD, Huang Y, et al
    Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  416. ESHLEMAN SH, Hudelson SE, Redd AD, Swanstrom R, et al
    Treatment as Prevention: Characterization of partner infections in the HIV Prevention Trials Network 052 trial.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  417. WYNDHAM-THOMAS C, Corbiere V, Selis E, Payen MC, et al
    Immune activation by Mycobacterium tuberculosis in HIV-infected and -uninfected subjects.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  418. THIRUMURTHY H, Masters SH, Rao S, Murray K, et al
    The Effects of Providing Fixed Compensation and Lottery-Based Rewards on Uptake of Medical Male Circumcision in Kenya: A Randomized Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S299-305.
    >> Share

  419. KAUFMAN ZA, DeCelles J, Bhauti K, Hershow RB, et al
    A Sport-Based Intervention to Increase Uptake of Voluntary Medical Male Circumcision Among Adolescent Male Students: Results From the MCUTS 2 Cluster-Randomized Trial in Bulawayo, Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S292-8.
    >> Share

  420. WILSON N, Frade S, Rech D, Friedman W, et al
    Advertising for Demand Creation for Voluntary Medical Male Circumcision.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S288-91.
    >> Share

  421. BAZANT E, Mahler H, Machaku M, Lemwayi R, et al
    A Randomized Evaluation of a Demand Creation Lottery for Voluntary Medical Male Circumcision Among Adults in Tanzania.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S280-7.
    >> Share

  422. SEMEERE AS, Castelnuovo B, Bbaale DS, Kiragga AN, et al
    Innovative Demand Creation for Voluntary Medical Male Circumcision Targeting a High Impact Male Population: A Pilot Study Engaging Pregnant Women at Antenatal Clinics in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S273-9.
    >> Share

  423. LEIBY K, Connor A, Tsague L, Sapele C, et al
    The Impact of SMS-Based Interventions on VMMC Uptake in Lusaka Province, Zambia: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S264-72.
    >> Share

  424. ZANOLINI A, Bolton C, Lyabola LL, Phiri G, et al
    Feasibility and Effectiveness of a Peer Referral Incentive Intervention to Promote Male Circumcision Uptake in Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 4:S257-63.
    >> Share

  425. SINGH JA
    Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S252-5.
    >> Share

  426. HUGHES JP, Emel L, Hanscom B, Zangeneh S, et al
    Design Issues in Transgender Studies.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S248-51.
    >> Share

  427. SISKIND RL, Andrasik M, Karuna ST, Broder GB, et al
    Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S243-7.
    >> Share

  428. REISNER SL, Radix A, Deutsch MB
    Integrated and Gender-Affirming Transgender Clinical Care and Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S235-42.
    >> Share

  429. ANDERSON PL, Reirden D, Castillo-Mancilla J
    Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S230-4.
    >> Share

  430. GRANT RM, Sevelius JM, Guanira JV, Aguilar JV, et al
    Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S226-9.
    >> Share

  431. GAROFALO R, Kuhns LM, Reisner SL, Mimiaga MJ, et al
    Behavioral Interventions to Prevent HIV Transmission and Acquisition for Transgender Women: A Critical Review.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S220-5.
    >> Share

  432. POTEAT T, Scheim A, Xavier J, Reisner S, et al
    Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S210-9.
    >> Share

  433. MAYER KH, Grinsztejn B, El-Sadr WM
    Transgender People and HIV Prevention: What We Know and What We Need to Know, a Call to Action.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 3:S207-9.
    >> Share

  434. KABAGAMBE EK, Ezeamama AE, Guwatudde D, Campos H, et al
    Plasma n6-fatty acid levels are associated with CD4 cell counts, hospitalization and mortality in HIV-infected patients.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  435. CHAILLON A, Smith DM, Vanpouille C, Lisco A, et al
    HIV Trafficking between Blood and Semen during Early Untreated HIV Infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  436. AGUILAR-JIMENEZ W, Villegas-Ospina S, Gonzalez S, Zapata W, et al
    Active and precursor forms of Vitamin D reduce HIV-1 infection in vitro.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  437. SONG R, Hall HI, Green TA, Szwarcwald CL, et al
    Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of Undiagnosed Infections in the United States.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  438. NICHOLAS KJ, Flaherty DK, Smith RM, Sather DN, et al
    Chronic HIV-1 infection impairs superantigen-induced activation of peripheral CD4+CXCR5+PD-1+ cells, with relative preservation of recall antigen-specific responses.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  439. HARTLING HJ, Jespersen S, Gaardbo JC, Sambleben C, et al
    Reduced IL-7R T cell expression and increased plasma sCD127 in late presenting HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  440. AARONS GA, Sommerfeld DH, Chi BH, Ezeanolue EE, et al
    Concept Mapping of PMTCT Implementation Challenges and Solutions Across 6 sub-Saharan African Countries in the NIH-PEPFAR PMTCT Implementation Science Alliance.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S202-6.
    >> Share

  441. CHIBWESHA CJ, Ford CE, Mollan KR, Stringer JS, et al
    Point-of-Care Virologic Testing to Improve Outcomes of HIV-Infected Children in Zambia: A Clinical Trial Protocol.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S197-201.
    >> Share

  442. MYER L, Phillips TK, Zerbe A, Ronan A, et al
    Optimizing Antiretroviral Therapy (ART) for Maternal and Child Health (MCH): Rationale and Design of the MCH-ART Study.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S189-96.
    >> Share

  443. NAPUA M, Pfeiffer JT, Chale F, Hoek R, et al
    Option B+ in Mozambique: Formative Research Findings for the Design of a Facility-Level Clustered Randomized Controlled Trial to Improve ART Retention in Antenatal Care.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S181-8.
    >> Share

  444. SHARMA M, Farquhar C, Ying R, Krakowiak D, et al
    Modeling the Cost-Effectiveness of Home-Based HIV Testing and Education (HOPE) for Pregnant Women and Their Male Partners in Nyanza Province, Kenya.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S174-80.
    >> Share

  445. KRAKOWIAK D, Kinuthia J, Osoti AO, Asila V, et al
    Home-Based HIV Testing Among Pregnant Couples Increases Partner Testing and Identification of Serodiscordant Partnerships.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S167-73.
    >> Share

  446. EZEANOLUE EE, Powell BJ, Patel D, Olutola A, et al
    Identifying and Prioritizing Implementation Barriers, Gaps, and Strategies Through the Nigeria Implementation Science Alliance: Getting to Zero in the Prevention of Mother-to-Child Transmission of HIV.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S161-6.
    >> Share

  447. PHARR JR, Obiefune MC, Ezeanolue CO, Osuji A, et al
    Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S154-60.
    >> Share

  448. PRICE JT, Wheeler SB, Stranix-Chibanda L, Hosek SG, et al
    Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S145-53.
    >> Share

  449. FAYORSEY RN, Chege D, Wang C, Reidy W, et al
    Mother Infant Retention for Health (MIR4Health): Study Design, Adaptations, and Challenges With PMTCT Implementation Science Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S137-44.
    >> Share

  450. REIMERS P, Israel-Ballard K, Spies L, Tanser F, et al
    A Protocol for a Cluster Randomized Trial on the Effect of a "feeding buddy" Program on adherence to the Prevention of Mother-To-Child-Transmission Guidelines in a Rural Area of KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S130-6.
    >> Share

  451. YOTEBIENG M, Thirumurthy H, Moracco KE, Edmonds A, et al
    Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S124-9.
    >> Share

  452. BOEHMER A, Audet CM, Blevins M, Gebi UI, et al
    Patient and Provider Satisfaction With a Comprehensive Strategy to Improve Prevention of Mother-to-Child HIV Transmission Services in Rural Nigeria.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S117-23.
    >> Share

  453. GIMBEL S, Rustagi AS, Robinson J, Kouyate S, et al
    Evaluation of a Systems Analysis and Improvement Approach to Optimize Prevention of Mother-To-Child Transmission of HIV Using the Consolidated Framework for Implementation Research.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 2:S108-16.
    >> Share

  454. PRASITSUEBSAI W, Teeraananchai S, Singtoroj T, Truong KH, et al
    Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.
    J Acquir Immune Defic Syndr. 2016;72:380-6.
    >> Share

  455. BUTLER K, Ritter JM, Ellis S, Morris MR, et al
    A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    J Acquir Immune Defic Syndr. 2016;72:363-71.
    >> Share

  456. GUST DA, Soud F, Hardnett F, Malotte CK, et al
    Evaluation of sexual risk behavior among study participants in the TDF2 PrEP study among heterosexual adults in Botswana.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  457. HAISSMAN JM, Haugaard AK, Knudsen A, Kristoffersen US, et al
    Marker of endothelial dysfunction asymmetric dimethylarginine is elevated in HIV infection but not associated with sub-clinical atherosclerosis.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  458. DAVIS NL, Miller WC, Hudgens MG, Chasela CS, et al
    Maternal and Breast Milk Viral Load: Impacts of Adherence on Peri-Partum HIV Infections Averted - the BAN Study.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  459. MOORE CL, Grulich AE, Prestage G, Gidding HF, et al
    Hospitalisation for Anxiety and Mood Disorders in HIV-infected and -Uninfected Gay and Bisexual Men.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  460. KEATING SM, Kassanjee R, Lebedeva M, Facente SN, et al
    Performance of the Bio-Rad Geenius HIV1/2 supplemental assay in detecting 'recent' HIV infection and calculating population incidence.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  461. ALFONSO YN, Bishai D, Nantongo A, Kakembo R, et al
    Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

    July 2016
  462. CHANG W, Chamie G, Mwai D, Clark TD, et al
    Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  463. SSEMMONDO E, Mwangwa F, Kironde JL, Kwarisiima D, et al
    Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  464. GUHA A, Brier MR, Ortega M, Westerhaus E, et al
    Topographies of cortical and subcortical volume loss in HIV and aging in the cART era.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  465. LELUTIU-WEINBERGER C, Golub SA
    Enhancing PrEP Access for Black and Latino Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  466. AULD AF, Shiraishi RW, Couto A, Mbofana F, et al
    A Decade of Antiretroviral Therapy Scale-up in Mozambique: Evaluation of Outcome Trends and New Models of Service Delivery Among more than 300,000 Patients Enrolled during 2004[FIGURE DASH]2013.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  467. KARITA E, Nsanzimana S, Ndagije F, Wall KM, et al
    Evolution of Couples Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  468. FRIEDLAND BA, Hoesley CJ, Plagianos M, Hoskin E, et al
    A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  469. ONU CC, Dworkin SL, Ongeri LG, Oyaro P, et al
    Sexual violence against HIV-positive women in the Nyanza region of Kenya: Is condom negotiation an instigator?
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  470. PILCHER CD, Ospina-Norvell C, Dasgupta A, Jones D, et al
    The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a U.S. Public Health Setting.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  471. BENGTSON AM, Pence BW, Gaynes BN, Quinlivan EB, et al
    Improving depression among HIV-infected adults: transporting the effect of a depression treatment intervention to routine care.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  472. TRIPLETTE M, Attia E, Akgun K, Campo M, et al
    The differential impact of emphysema on respiratory symptoms and six-minute walk distance in HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  473. BEER L, Bradley H, Mattson CL, Johnson CH, et al
    Trends in racial and ethnic disparities in antiretroviral therapy prescription and viral suppression in the United States, 2009-2013: Trends in disparities in HIV care.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  474. PAN SW, Zhang Z, Li D, Carpiano RM, et al
    Religion and HIV sexual risk among men who have sex with men in China.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  475. SOBIESZCZYK ME, Werner L, Mlisana K, Naicker N, et al
    Metabolic syndrome after HIV acquisition in South African women.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  476. SHRESTHA RK, Farnham PG, Whitham HK, Sansom SL, et al
    Challenges in Estimating Effectiveness of Condom Distribution Campaigns to Prevent HIV Transmission.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  477. YOUSEF KP, Meixenberger K, Smith MR, Somogyi S, et al
    Inferring HIV-1 transmission dynamics in Germany from recently transmitted viruses.
    J Acquir Immune Defic Syndr. 2016.
    >> Share


  478. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    J Acquir Immune Defic Syndr. 2016;72:e82.
    >> Share

  479. DIRIX V, Schepers K, Massinga-Loembe M, Worodria W, et al
    Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
    J Acquir Immune Defic Syndr. 2016;72:344-52.
    >> Share

  480. GIRARD A, Vergnon-Miszczycha D, Depince-Berger AE, Roblin X, et al
    Brief Report: A High Rate of beta7+ Gut-Homing Lymphocytes in HIV-Infected Immunological Nonresponders is Associated With Poor CD4 T-Cell Recovery During Suppressive HAART.
    J Acquir Immune Defic Syndr. 2016;72:259-65.
    >> Share

    June 2016
  481. SUPERVIE V, Marty L, Lacombe JM, Dray-Spira R, et al
    Looking beyond the cascade of HIV care to end the AIDS epidemic: estimation of the time interval from HIV infection to viral suppression.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  482. CONROY AA, Gamarel KE, Neilands TB, Sauceda JA, et al
    Partner reports of HIV viral suppression predict sexual behavior in serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  483. SAMUEL R, Julian MN, Paredes R, Parboosing R, et al
    HIV-1 Drug resistance by Ultra-deep sequencing following short course Zidovudine, single dose Nevirapine and single dose Tenofovir with Emtricitabine for pMTCT.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  484. CLIFFORD GM, de Vuyst H, Tenet V, Plummer M, et al
    Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  485. PECK RN, Wang RJ, Mtui G, Smart L, et al
    Linkage to primary care and survival after hospital discharge for HIV-infected adults in Tanzania: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  486. SLAVEN JE, Decker BS, Kashuba AD, Atta MG, et al
    Plasma and Intracellular Concentrations in HIV-infected Patients Requiring Hemodialysis Dosed with Tenofovir Disoproxil Fumarate and Emtricitabine: TDF and FTC in HD.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  487. KUNIHOLM MH, O'Brien TR, Prokunina-Olsson L, Augenbraun M, et al
    Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women.
    J Acquir Immune Defic Syndr. 2016;72:162-70.
    >> Share

  488. SHET A, Nagaraja P, Dixit NM
    Viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of HIV-1 subtype C.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  489. JUDGE CJ, Sandberg JK, Funderburg NT, Sherman KE, et al
    CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  490. FRAM F, Church F, Sundaram M, Sgaier SK, et al
    Employing Demand-Based Volumetric Forecasting to Identify Potential for and Roles of Devices in Scale-Up of Medical Male Circumcision in Zambia and Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S83-9.
    >> Share

  491. MILOVANOVIC M, Taruberekera N, Martinson N, Lebina L, et al
    Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S78-82.
    >> Share

  492. MUSIIGE AM, Ashengo TA, Stolarsky G, Dialwa RT, et al
    Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S73-7.
    >> Share

  493. KUFA T, Chetty-Makkan C, Maraisane M, Charalambous S, et al
    Delivering PrePex Medical Male Circumcision Services Through a Mobile Clinic: The Experience From a Pilot Project in North West Province, South Africa.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S69-72.
    >> Share

  494. MAVHU W, Hatzold K, Ncube G, Xaba S, et al
    Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S63-8.
    >> Share

  495. CUMMINGS B, Necochea E, Ferreira T, Soares B, et al
    Acceptability and Satisfaction Associated With the Introduction of the PrePex Circumcision Device in Maputo, Mozambique.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S56-62.
    >> Share

  496. SAMUELSON J, Hargreave T, Ridzon R, Farley T, et al
    Innovative Methods of Male Circumcision for HIV Prevention-Getting the Right Evidence.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S5-S12.
    >> Share

  497. FELDBLUM P, Martinson N, Bvulani B, Taruberekera N, et al
    Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S43-8.
    >> Share

  498. FELDBLUM PJ, Zulu R, Linyama D, Long S, et al
    Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S30-5.
    >> Share

  499. BARONE MA, Li PS, Zulu R, Awori QD, et al
    Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S18-23.
    >> Share

  500. AWORI QD, Lee RK, Li PS, Zulu R, et al
    Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.
    J Acquir Immune Defic Syndr. 2016;72 Suppl 1:S13-7.
    >> Share

  501. SO-ARMAH KA, Tate JP, Chang CH, Butt AA, et al
    Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    J Acquir Immune Defic Syndr. 2016;72:206-213.
    >> Share

    May 2016
  502. BANGANI N, Nakiwala J, Martineau AR, Wilkinson RJ, et al
    HIV-1 infection impairs CD16 and CD35 mediated opsonophagocytosis of M.tuberculosis by human neutrophils.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  503. TABERNILLA A, Rego-Perez I, Grandal M, Pernas B, et al
    European Mitochondrial Haplogroups Impact on Liver Fibrosis Progression among HCV and HIV/HCV Coinfected Patients from Northwest Spain.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  504. CARRICO AW, Zepf R, Meanley S, Batchelder A, et al
    When the Party is Over: A Systematic Review of Behavioral Interventions for Substance-Using Men who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  505. MATHAD JS, Gupte N, Balagopal A, Asmuth D, et al
    Sex-related Differences in Inflammatory and Immune Activation Markers before and after combined Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  506. MONROE AK, Lau B, Mugavero MJ, Mathews WC, et al
    Heavy Alcohol Use is Associated with Worse Retention in HIV Care.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  507. HUERGA H, Van Cutsem G, Ben Farhat J, Reid M, et al
    Who needs to be targeted for HIV testing and treatment in KwaZulu-Natal? Results from a population-based survey.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  508. TUFA DM, Ahmad F, Chatterjee D, Ahrenstorf G, et al
    HIV-1 infection results in increased frequency of active and inflammatory slanDCs that produce high level of IL-1beta.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  509. BERGIN P, Langat R, Omosa-Manyonyi G, Farah B, et al
    Assessment of anti-HIV-1 antibodies in Oral and Nasal Compartments of Volunteers from Three different Populations.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  510. ROBERTS ST, Haberer J, Celum C, Mugo N, et al
    Intimate partner violence and adherence to HIV pre-exposure prophylaxis (PrEP) in African women in HIV serodiscordant relationships: A prospective cohort study.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  511. WENDELKEN LA, Jahanshad N, Rosen HJ, Busovaca E, et al
    ApoE epsilon4 is Associated with Cognition, Brain Integrity and Atrophy in HIV Over Age 60.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  512. E-B ROSSHEIM A, Cunningham TD, Hair PS, Shah T, et al
    Effects of Well-Controlled HIV Infection on Complement Activation and Function.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  513. GALLANT J, Brunetta J, Crofoot G, Benson P, et al
    Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) in HIV-1/Hepatitis B Coinfected Adults.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  514. YAHYAEI S, Biasin M, Saulle I, Gnudi F, et al
    Identification of a Specific miRNA Profile in HIV Exposed Seronegative Individuals.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  515. MCHUGH G, Rylance J, Mujuru H, Nathoo K, et al
    Chronic morbidity among older children and adolescents at diagnosis of HIV infection.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  516. OKELLO S, Asiimwe SB, Kanyesigye M, Muyindike WR, et al
    D-dimer levels and traditional risk factors are associated with incident hypertension among HIV-infected individuals initiating antiretroviral therapy in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  517. WEISS JJ, Konstantinidis I, Boueilh A, Fierer DS, et al
    Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults with HIV Infection and Hypertension or Chronic Kidney Disease.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  518. HERRIN M, Tate JP, Akgun KM, Butt AA, et al
    Weight Gain and Incident Diabetes among HIV Infected-Veterans Initiating Antiretroviral Therapy Compared to Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  519. MACLENNAN CA, Richter A, Hodson J, Faustini S, et al
    Immunization of HIV-infected adults in the UK with Haemophilus influenzae b/meningococcal C glycoconjugate and pneumococcal polysaccharide vaccines.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  520. BEYMER MR, Weiss RE, Halkitis PN, Kapadia F, et al
    Disparities within the Disparity - Determining HIV Risk Factors among Latino Gay and Bisexual Men Attending a Community-Based Clinic in Los Angeles, California.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  521. RAMGOPAL M, Osiyemi O, Zorrilla C, Crauwels HM, et al
    Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  522. ROY M, Muyindike W, Vijayan T, Kanyesigye M, et al
    Use of symptom screening and sputum microscopy testing for active tuberculosis case detection among HIV-infected patients in real-world clinical practice in Uganda.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  523. BRAUNSTEIN SL, Robertson MM, Myers J, Nash D, et al
    Using HIV Viral Load from Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  524. KNUDSEN A, Christensen TE, Thorsteinsson K, Ghotbi AA, et al
    Microbiota dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82Rubidium PET/CT.
    J Acquir Immune Defic Syndr. 2016.
    >> Share

  525. TSUCHIYA K, Hayashida T, Hamada A, Oka S, et al
    Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants.
    J Acquir Immune Defic Syndr. 2016;72:11-4.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016